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SUMMARY 
Activity-dependent neuronal plasticity is a fundamental mechanism 
through which the nervous system adapts to sensory experience. Several 
lines of evidence suggest that parvalbumin (PV+) interneurons are 
essential in this process, but the molecular mechanisms underlying the 
influence of experience on interneuron plasticity remain poorly understood. 
Perineuronal nets (PNN) enwrapping PV+ cells are long-standing 
candidates for playing such a role, yet their precise contribution has 
remained elusive. We show that the PNN protein Brevican is a critical 
regulator of interneuron plasticity. We find that Brevican simultaneously 
controls cellular and synaptic forms of plasticity in PV+ cells by regulating 
the localization of potassium channels and AMPA receptors, respectively. 
By modulating Brevican levels, experience introduces precise molecular 
and cellular modifications in PV+ cells that are required for learning and 
memory. These findings uncover a molecular program through which a 
PNN protein facilitates appropriate behavioral responses to experience by 
dynamically gating PV+ interneuron function.  
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INTRODUCTION 
Experience-dependent plasticity endows neural circuits in the cerebral cortex with the 
flexibility required for adapting to a continuously changing environment, thereby 
contributing to sensory perception, cognition and behavior. The maintenance of precise 
neuronal coding during fluctuations in activity requires the balanced interaction between 
excitation and inhibition (Froemke, 2015; Hensch et al., 1998), a process that is 
dynamically sustained by the function of cortical parvalbumin-expressing (PV+) 
interneurons (Xue et al., 2014). Although several lines of evidence emphasize pivotal 
roles for PV+ cells in controlling the gain of sensory-related responses and learning 
(Wilson et al., 2012; Yazaki-Sugiyama et al., 2009), the molecular and cellular 
mechanisms by which PV+ interneurons influence these processes are poorly understood. 
PV+ cells can adapt their intrinsic properties (cellular plasticity) and outputs (synaptic 
plasticity) in response to sensory experience. These cells display a remarkable dynamism 
that allows them to exist in different ‘cell states’ or configurations, depending on the 
behavioral context (Bloodgood et al., 2013; Dehorter et al., 2015; Donato et al., 2013; 
Lagler et al., 2016). While the functional relevance of this novel form of experience-
dependent plasticity during behavior is clear (Donato et al., 2013), the molecular 
mechanisms regulating the adaptability of PV+ interneurons to changing levels of 
neuronal activity are largely unknown. The lack of information about these processes is 
particularly striking because PV+ cell dysfunction has been linked to impaired cognition 
in psychiatric disorders (Cardin et al., 2009; Hu et al., 2014; Sohal et al., 2009). Hence, 
the identification of the relevant molecular mediators of this form of plasticity may offer 
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novel therapeutic strategies to recover from deficits in perception, learning and memory 
associated with a repertoire of diseases.  
The induction and expression of neural plasticity – cellular and synaptic – relies on 
complex interactions between neurons and their extracellular environment. The 
extracellular matrix contains potential candidates for modulating neuronal responses to 
activity changes. For instance, most cortical PV+ interneurons are wrapped by a 
specialization of the extracellular matrix known as perineuronal nets (PNNs), that 
includes chondroitin sulfate proteoglycans (CSPGs) (Deepa et al., 2006). The maturation 
of PNNs around PV+ cells coincides with the closure of the critical period, a window of 
enhanced plasticity across different brain regions during early postnatal life (Takesian 
and Hensch, 2013). It has been suggested that PNNs contribute to this process by 
promoting synapse stabilization and limiting synaptic rearrangements beyond the critical 
period for plasticity (Pizzorusso et al., 2002). Consistently, pharmacological degradation 
of CSPGs in the adult reactivates cortical plasticity and enhances learning (Gogolla et al., 
2009). However, in spite of the unequivocal role of PNNs in the regulation of cortical 
plasticity, the precise mechanism through which PNNs mediate this process remains a 
mystery. 
Brevican (BCAN) is one of the most abundant CSPGs in the brain and a fundamental 
component of the PNNs (Frischknecht et al., 2014). It is expressed in several brain 
regions from early postnatal development, mostly inside glial cells and around neurons 
(Seidenbecher et al., 2002). Though its function is currently unclear, three lines of 
evidence suggest that BCAN may play a key role regulating experience-dependent 
plasticity in cortical circuits: (i) BCAN is a component of PNNs surrounding PV+ cells 
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(Valenzuela et al., 2014); (ii) BCAN is present in cell membranes and synaptosomal 
fractions (Seidenbecher et al., 2002); and (iii) BCAN is required for long-term 
potentiation (LTP) in the hippocampus (Brakebusch et al., 2002). 
Here we identify the molecular mechanism through which the PNN protein BCAN 
influences cellular and synaptic plasticity in response to changes in the environment. We 
demonstrate that BCAN shapes the intrinsic properties of PV+ interneurons and sculpts 
their synaptic inputs by controlling the localization of potassium channels and the levels 
of synaptic AMPA receptors, respectively. Moreover, in contrast to the long-standing 
view that PNN proteins are static and function just as a break for synaptic plasticity 
(Nabel and Morishita, 2013; Takesian and Hensch, 2013), we show that BCAN is 
dynamically regulated by activity and that its function is fundamentally required for 
spatial working and short-term memories. These results therefore reveal that BCAN plays 
a key role in gating the function of PV+ interneurons, thereby enabling coordinated 
circuit responses to experience. Our findings clarify the molecular and cellular events 
underlying the function of PNN proteins in neuronal plasticity. 
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RESULTS 
Brevican is expressed in PV+ interneurons and has a synaptic localization  
Brevican protein (BCAN) has been found in several brain regions and its expression is 
described as a diffuse, dense net-like structure around mostly PV+ cells (Valenzuela et 
al., 2014). However, the precise source of BCAN remains unclear. We found that in the 
hippocampus, Brevican transcripts (Bcan) are restricted to glial and PV+ cells (Figures 
1A-1D and S1A-S1D). BCAN has different splicing isoforms encoding secreted 
(BCAN1) and GPI-anchored (BCAN2) proteins (Seidenbecher et al., 1995). We observed 
that whereas both isoforms were co-expressed in glia and PV+ interneurons, the latter 
population of cells showed a bias towards Bcan2 expression (Figures 1D-1G). The 
percentage of PV+ cells that expressed BCAN increased substantially in the second 
postnatal week, when the maximum fraction of BCAN+/PV+ cells was found (Figures 
1H, 1I and S1E). BCAN kept accumulating around PV+ cells after the third postnatal 
week (Figure S1F). Interestingly, we observed that BCAN+/PV+ cells exhibit higher PV 
levels than BCAN-/PV+ cells (Figures 1J, 1K and S2A). Of note, although Brevican is 
also expressed throughout the neocortex (Figures S1G, S1H), no trace of BCAN was 
detected in chandelier cells (0 out of 9 cells, Figure S1B),  
It has been shown that PNNs ensheath synaptic contacts, suggesting a possible role 
during synapse formation (Hockfield and McKay, 1983). We observed that the frequency 
and intensity of BCAN staining in PV+ cells increased concurrently with the 
development of synaptic inputs onto these cells (Figures S1E, S1F, S1I). In the 
hippocampus, the soma of PV+ basket cells receives both excitatory inputs from 
pyramidal cells and inhibitory inputs from interneurons. Among these synapses, we found 
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that BCAN was particularly enriched in excitatory terminals (VGlut1+) (Figures 1L-1N). 
In contrast, only a small percentage of inhibitory puncta (Syt2+ PV+ or GAD65+ PV-) 
contacting PV+ cells were BCAN+ (Figures S1J-S1O). To analyze the subcellular 
location of BCAN with nanoscale resolution in hippocampal sections, we developed a 
novel method for multi-color single-molecule localization-based super-resolution 
microscopy (Betzig et al., 2006), termed SD-dSTORM (spectral-demixing stochastic 
optical reconstruction microscopy) (Winterflood et al., 2015) (Figures 1O-1R and S1P-
S1S). We first identified somatic synapses apposed to PV+ cells by immunolabeling the 
synaptic proteins Bassoon (pre-synapse) and Homer1 (post-synapse). As described before 
(Dani et al., 2010), we observed typical focal planes with Bassoon and Homer1 flanking 
the synaptic cleft (Figure 1P). Using Bassoon as a reference, we focused on the axial 
distribution of BCAN and found that it was located both pre- and postsynaptically 
(Figures 1O-1R). Next, we observed that the average radial position of BCAN relative to 
the center of the synaptic complex is predominantly peripheral (Figures 1P and 1R). 
Altogether, our findings reveal that BCAN – mostly BCAN2 – is expressed in a large 
fraction of PV+ cells and that it flanks the excitatory synapses received by these cells. 
Brevican identifies a subpopulation of PV+ basket cells 
PV+ basket cells comprise a highly diverse population of interneurons that integrate in 
multiple microcircuits and exhibit diverse firing patterns and molecular programs 
(Dehorter et al., 2015). In addition to the different PV levels exhibited by BCAN+ and 
BCAN- PV+ cells (Figures 1J, 1K and S2A), using pre- (VGlut1) and postsynaptic 
markers (PSD95) we found that BCAN+/PV+ cells receive a higher number of excitatory 
inputs than BCAN-/PV+ cells (Figures 2A-2C and S2B, S2C). 
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We then enquired whether BCAN+ and BCAN- PV cells could be distinguished on the 
basis of their electrophysiological properties (Figures 2D-M). BCAN+/PV+ cells are less 
excitable, showing lower input resistance than BCAN-/PV+ cells (Figures 2I and Table 
S1). However, BCAN+/PV+ cells also seem better tuned to operate at higher spiking 
frequencies than their counterparts, as they display higher maximum firing frequency, 
less spike frequency adaptation, narrower action potential half-width, and an earlier fast 
after-hyperpolarization (fAHP) time than BCAN-/PV+ cells (Figures 2D-M). Our 
findings reveal that PV+ cells expressing BCAN have a distinct profile: they receive 
more glutamatergic synapses, are less excitable and have faster responses than PV+ cells 
lacking BCAN. 
Brevican controls synapses and intrinsic properties of PV+ basket cells  
BCAN locates at the flanks of excitatory synapses and its peak of expression coincides 
with the maturation of these inputs to PV+ cells (Figure S1I). To test a potential function 
of BCAN in the wiring of PV+ cells, we analyzed the impact of BCAN deletion on the 
synaptic inputs these interneurons receive. Whereas the density of excitatory synapses 
impinging on the soma of PV+ cells and the levels of PV expression were comparable in 
control and Bcan mutant mice at early stages of synaptic development (P15), PV+ cells 
received less excitatory inputs in Bcan knockout mice at P30 (Figures 3A-3D and S3A, 
S3B). Consistently, Bcan mutants exhibited a lower frequency – but not amplitude – of 
miniature excitatory postsynaptic currents (mEPSCs), which also had a slower decay 
(Figures 3E-3I). These findings indicated that, although BCAN is dispensable for the 
initial contact of excitatory boutons with PV cells, it is critical for their maturation. Of 
note, we detected a reduction in PV protein levels at P30 but not at P15, whilst the total 
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density of PV+ cells remained unaltered (Figures 3J-3M and S3C). We observed a similar 
reduction in the density of excitatory puncta in adult mice (P60, Figures S3D-F), that 
rules out a potential delay in synapse formation. 
To test whether BCAN function is also required for the formation of perisomatic 
inhibitory synapses in PV+ cells, we examined inputs from other PV+ and 
Cholecystokinin-positive (CCK+) basket cells (Karson et al., 2009). We observed that the 
density and size of Syt2+ (a presynaptic marker of PV+ cells) terminals contacting the 
soma of PV+ cells as well as the density of Syt2+/Gephyrin+ synapses were similar 
between both genotypes (Figures S3G-S3K). To analyze the contribution of CCK+ 
interneurons, we combined the GAD65 synaptic protein with the presynaptic receptor 
CB1, highly enriched in CCK+ axon terminals (Katona et al., 1999) (Figures S3G, S3L-
S3N). We found no significant differences in the density of GAD65+/CB1+ synapses 
between control and Bcan mutant mice (Figures S3L-S3N). Consistent with these results, 
we found no differences in miniature inhibitory postsynaptic currents (mIPSCs) (Figures 
S3O-S). In agreement with its highly specific location at excitatory synapses, these 
results revealed that BCAN regulates the maturation of excitatory – but not inhibitory – 
inputs onto PV+ cells. 
Since BCAN+/PV+ cells exhibit different electrophysiological properties than BCAN-
/PV+ interneurons, we examined whether loss of BCAN would alter the intrinsic 
properties of BCAN+/PV+ cells. We found that PV+ interneurons in Bcan mutant mice 
exhibited broader action potentials with smaller fAHP phase (Figures 3N-3V and Table 
S2). Consistently, the input-output curve was below that of Bcan+/+ cells (Figures 3V). 
Moreover, we found that deletion of BCAN enhanced the intrinsic excitability of PV+ 
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cells by decreasing the action potential threshold and latency to first action potential 
(Figures 3O-3Q and Table S2). To examine how the changes in the excitatory drive and 
excitability of Bcan mutant PV+ interneurons ultimately influenced the flow of 
information from pyramidal to PV+ cells, we recorded spontaneous excitatory 
postsynaptic currents (sEPSCs) in PV+ cells (Figures S3T-S3X). We observed a 
decreased frequency of sEPSCs and slower decay kinetics in Bcan mutant mice (Figures 
S3U and S3X). Our findings therefore demonstrate that BCAN is necessary for the 
maturation of excitatory inputs onto PV+ interneurons, as well as for the expression of 
their normative intrinsic properties. 
A cell-autonomous function for Brevican in Parvalbumin cells 
BCAN is found around the soma of PV+ cells, but its source is unclear, as is its 
precise cellular contribution to the Bcan mutant phenotype. To investigate this, we first 
explored whether cell-type specific knockdown of BCAN in PV+ interneurons was 
sufficient to mimic the synaptic and cellular phenotype found in Bcan mutant mice. We 
engineered Cre-dependent conditional constructs expressing a short-hairpin RNA 
(shRNA) targeting a common region for both Bcan1 and Bcan2 (shBcan, Figure S4A). 
We packed this construct in adeno-associated viral vectors (AAV) in which 
recombination was reported by mCherry (Figures 4A-4C), and the functionality of these 
constructs was assayed in vitro (Figures S4A-F). We co-injected low titer Cre-dependent 
shBcan and YFP-expressing viruses into the hippocampal CA1 region of PV-Cre mice at 
P12 and analyzed the density of synapses in sparsely labeled PV+ cells at P30 (Figures 
4A-4G). Expression of shBcan led to a loss of BCAN in PV+ cells, causing a decrease in 
the number of excitatory – but not inhibitory – afferents onto knockdown (mCherry+) 
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compared to control (YFP+) PV+ cells (Figures 4C-G and S4G-H) and a shift towards 
lower PV levels (Figure 4H). 
We next used a similar approach to explore how PV-specific loss of BCAN affects the 
intrinsic properties of PV+ cells. We found that PV+ cells that expressed shBcan 
mimicked Bcan mutants for some variables but with a stronger trend when compared to 
Bcan+/+ mice (Figures 4I-U and Table S3). Altogether, these experiments demonstrated 
that cell-autonomous expression of BCAN in PV+ interneurons controls their excitatory 
inputs and some of their intrinsic properties. 
 
Isoform-specific roles for Brevican 
To explore which BCAN isoform is required for the maturation of excitatory synapses, 
we attempted to rescue cell-autonomously the synaptic deficit observed in Bcan mutant 
interneurons by overexpressing Cre-dependent HA-tagged Bcan1 or Bcan2 in 
hippocampal PV+ cells (Figures 5A-C and S4B). HA reported BCAN1 and BCAN2 
expression accurately (Figure S5A). Remarkably, whereas BCAN1 resembled other 
classical PNN markers, BCAN2 expression was dotted, similar to that commonly 
observed for synaptic markers (Figures 5D, 5I and S5A). We observed that while Bcan1 
expression does not rescue the synaptic phenotype found in Bcan mutant PV+ cells, 
Bcan2 does (Figures 5E-5H, 5J-5M, S5B-S5G). The synaptic function of BCAN2 
required the GPI-anchor, since overexpression of a Bcan2 that lacks the GPI-domain led 
to an even more pronounced synaptic phenotype compared to Bcan-/- mice (Figure S5D-
S5F). Interestingly, both Bcan1 and Bcan2 were able to rescue PV levels (Figures 5H and 
5M), suggesting that it could change both as a result of modifications in the excitatory 
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drive of PV+ cells as well as by independent cellular mechanisms. Altogether, these 
results reveal an isoform-specific function for Bcan2 in the maturation of the excitatory 
synapses on PV+ interneurons. 
Interestingly, we observed a milder reduction of excitatory inputs contacting Bcan 
knock-down compared to Bcan knockout PV+ cells (Figures S4G and S5H). 
Consistently, expression of Bcan2 in PV+ cells only partially rescued the density of 
VGlut1+ puncta (Figure S5C). As BCAN is also expressed in glial cells (Figure 1) and 
astrocytes contribute to synapse development (Clarke and Barres, 2013), we attempted to 
rescue the Bcan mutant PV+ cells wiring phenotype by driving Bcan1 or Bcan2 
expression in astrocytes (Figures 5N-5X). BCAN1 was secreted from astrocytes, and 
concentrated around both a small number of PV+ cells (Figures 5Q, 5R and S5I) and few 
pyramidal cells (Figure S5J), as described before (Carstens et al., 2016). BCAN2 was 
instead cleaved and released from astrocytes in the tissue without displaying any cell-type 
bias (Figures 5S and 5T). When expressed in astrocytes, Bcan2 – but not Bcan1 –rescued 
the synaptic phenotype found in Bcan mutant PV+ cells (Figures 5U-5X and S5M). 
However, neither Bcan1 nor Bcan2 expression in astrocytes led to a rescue of PV levels 
(Figure S5L). Altogether, our results suggest that Bcan2 expression in PV+ cells 
regulates the maturation of their excitatory inputs, along with a potential contribution 
from astrocytes. 
The marked alteration in the intrinsic properties of PV+ cells upon Bcan knock-down 
suggested a cell-autonomous role for BCAN in the regulation of the firing properties of 
PV+ cells. To determine whether this was due to the lack of a specific Bcan isoform, we 
asked whether expression of either Bcan1 or Bcan2 alone was sufficient to rescue the 
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phenotype found in Bcan mutant mice (Figures 5A-C). Our results revealed that none of 
the two isoforms was by itself sufficient to restore normative intrinsic properties in Bcan 
mutant mice (Figures S5M-W and Table S4), suggesting that either both isoforms may 
cooperatively regulate the firing behavior of PV+ interneurons or a more complex 
scenario may be taking place. 
Brevican controls AMPA receptors and voltage-gated potassium channels 
in PV+ cells 
Our results demonstrate that BCAN – more specifically, BCAN2 – is necessary for the 
maturation (Figure 3D) but not initial assembly (Figure S3B) of excitatory synapses onto 
PV+ cells. These findings prompted us to investigate how BCAN may regulate the 
differentiation of excitatory synapses. 
During postnatal development, neurons edit the composition of their glutamate 
receptors (Hu et al., 2014). This process is particularly important in PV+ interneurons, 
where transmission is primarily mediated by GluA2-lacking, calcium-permeable AMPA 
receptors (AMPARs) with GluA1 and GluA4 subunits (Fuchs et al., 2007; Matta et al., 
2013). The slower decay of mEPSCs and sEPSCs found in Bcan mutant mice suggested 
an altered subunit composition of AMPARs (Figures 3I and S3X). To investigate whether 
BCAN may contribute to the regulation of AMPARs in PV+ cells, we performed co-
immunoprecipitation (IP) experiments in hippocampal lysates. We found that BCAN 
protein co-immunoprecipitated with different AMPAR subunits but not with NMDA or 
metabotropic glutamate receptors (Figure 6A and S6A). We next examined whether 
BCAN is required for the expression of GluA1 and GluA4-containing AMPARs at 
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synapses. Analysis of hippocampal synaptosome fractions obtained from Bcan mutant 
mice revealed a reduction of synaptic GluA1 compared to controls (Figures 6B, 6C and 
S6E). This reduction was accompanied by an increase of GluA1 in the non-synaptic 
plasma membrane fraction, while no differences were observed in total or cytoplasmic 
GluA1 protein (Figures 6B, 6C, S6D, and S6E). In contrast, levels of GluA4 were 
unchanged (Figures S6B and S6C). Interestingly, although Bcan2 – but not Bcan1 – is 
responsible for the synaptic phenotype found in Bcan mutants (Figures 5G and 5L), both 
BCAN1 and BCAN2 co-immunoprecipitated with GluA1 in vitro (Figure S6I). 
Altogether, these results suggested that BCAN may be involved in the trafficking of 
GluA1 AMPAR subunits from extrasynaptic to synaptic sites. 
Since GluA1 subunits are expressed in both pyramidal cells and interneurons, we 
sought to investigate the neuronal population responsible for the changes in GluA1 
subcellular location. Using three-color STORM microscopy in brain sections of wild-type 
mice, we measured the radial position of BCAN and GluA1 in relation to the synaptic 
marker Bassoon contacting PV+ cells. We observed that BCAN and GluA1 partially 
overlap in the outer domain of Bassoon (Figures 6D and 6E). We next analyzed the 
density of GluA1+ synaptic clusters (Figures 6F-6M and Figure S6F) and found a 50% 
reduction in Bcan mutant and Bcan knock-down PV+ cells (Figures 6H and 6L). Cell 
type-specific loss of GluA1 is in itself sufficient to decrease the excitatory afferents onto 
PV+ cells, as the density of excitatory synapses was reduced in PV-Cre;GluA1F/F mice 
compared to controls (Figures 6N-6P and S6G). This suggests that the PV-specific loss of 
GluA1 consequent to disruption of BCAN expression would suffice to produce a deficit 
in excitatory synaptic inputs. Consistent with the synaptic function of Bcan2, only this 
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isoform’s expression restored the density of synaptic GluA1+ clusters in Bcan mutant 
PV+ cells (Figures 6I, 6J, and 6M). Our results thus demonstrate that BCAN regulates 
excitatory inputs contacting PV+ interneurons at least in part by controlling the normal 
localization and levels of GluA1 AMPAR subunits. 
BCAN also regulates the electrophysiological properties of PV+ cells. Some such 
properties are regulated by fast-activating voltage-gated K+ conductances mediated by 
Kv1 and Kv3 potassium channels (Hu et al., 2014). We focused our analysis in the Kv1.1 
and Kv3.1 subunits, which are enriched in PV+ cells and are key for the characteristics of 
their action potential waveform (Du et al., 1996; Goldberg et al., 2008). We found that 
both BCAN1 and BCAN2 form protein complexes with Kv1.1 and Kv3.1b (Figures S6H 
and S6I). Consistently, we observed a prominent decrease in the density of Kv3.1b 
membrane clusters – but not in the total Kv3.1b protein – in Bcan deficient PV+ cells 
(Figures 6Q-6U), which may support deficits in spike waveform, duration and frequency 
found in the mutants (Figures 3N, 3U, and 3V). We also found a decrease in the density 
of Kv1.1 membrane clusters in PV+ cells – as well as in Kv1.1 total protein – in Bcan 
mutant mice (Figures 6V-6Y), a finding that is consistent with the reduction in action 
potential threshold and latency observed in the mutants (Figures 3O-3Q). BCAN 
knockdown in PV+ interneurons also reduced the density of Kv3.1b but not Kv1.1 clusters 
in these cells (Figures 6S, 6U, 6X, and 6Z). Altogether, these results suggest that cell-
autonomous expression of BCAN in PV+ cells controls fundamental properties of the 
action potential by regulating the composition of specific channels, including Kv3.1b-
containing potassium channels. 
Brevican expression is dynamically regulated by activity  
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AMPA glutamate receptors, particularly those containing GluA1 subunits, are recruited 
to the synapse in an activity-dependent manner (Henley and Wilkinson, 2016) but the 
molecular mechanisms by which they are trafficked to and held there are not fully 
understood (Turrigiano, 2012). Since BCAN controls the expression of GluA1 at the 
synapse, we hypothesized that it might coordinate GluA1 subunit clustering by 
dynamically responding to changes in activity. To test this idea, we analyzed the 
expression of BCAN in three different experimental paradigms of altered network 
activity. First, we used pharmacology in hippocampal cultures: increasing activity with 
the GABAA receptor antagonist Gabazine led to a 47% decrease in BCAN levels (Figures 
7A and 7B). Reducing activity via L-type calcium channel blockade (Nifedipine) resulted 
in an increase in BCAN (Figures 7A and 7B). 
Second, we obtained tissue from surgical resections of patients with temporal lobe 
seizures, a pathological model of excessive neural activity. We observed that BCAN was 
decreased in epilepsy patients compared to controls, suggesting that BCAN levels are 
controlled by activity also in the human cortex (Figures 7C and 7D). This decrease was 
not due to a reduction in the number of interneurons, as protein levels for the interneuron 
marker Lhx6 were similar in both conditions (Figures S7A and S7B). 
To confirm that BCAN is dynamically regulated by activity under more 
physiological conditions, we analyzed changes in BCAN levels associated to training 
(Figures S7C and S7D). Previous studies have shown shifts in hippocampal PV+ cell 
network configuration after spatial learning (Dehorter et al., 2015; Donato et al., 2013). 
Consistently, 4 days of Morris Water Maze (MWM) training caused a shift to low PV 
expression in PV+ cells (Figure S7E). During the learning phase of the task (day 4), 
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BCAN expression also shifted to lower levels, leading to a decrease in the proportion of 
BCAN+ cells among the PV+ interneuron population (Figures 7E-7H). Interestingly, 
upon learning accomplishment (day 10), PV expression shifted to a high-PV network 
configuration and BCAN expression returned to baseline levels (Figures 7H and S7F-
S7H). To strengthen these observations, we analyzed BCAN levels in mice exposed to an 
enriched environment (EE). We observed that 30 days of EE caused a shift to low PV 
expression compared to mice housed in standard conditions (Figure S7J). Consistent with 
a remodeling of the PV+ interneuron network, we also found that EE decreases the levels 
of BCAN compared to controls (Figures 7I-7K). Consequently, the percentage of 
BCAN+/PV+ cells was also reduced (Figure 7L). Such changes in the BCAN levels led 
to synaptic modifications onto PV+ cells (Figure 7M), as observed in Bcan mutants 
(Figure 3). We next demonstrated that both BCAN isoforms were regulated by activity. A 
decrease in both Bcan2 and Bcan1 levels was detected since 4 days of EE (Figures 7N 
and 7O) when no change in the PV and BCAN levels or in the density of excitatory 
synapses were yet observed (Figures S7K-S7O). Noteworthy, the reduction of Bcan2 – 
but not Bcan1 – was still maintained after 30 days of EE (Figures 7N, 7O and S7N, S7O). 
Although both Bcan isoforms seem to be regulated by activity, the increase in the 
Bcan1/Bcan2 ratio suggests that Bcan2 may be the main isoform that responds to changes 
in activity (Figure S7P). Altogether, these experiments demonstrate that BCAN levels are 
dynamically regulated by activity under physiological conditions. 
Brevican mutants have cognitive deficits  
The activity-dependent dynamics of BCAN could be a critical mechanism for regulating 
plasticity during learning and behavior. GluA1-containing AMPARs are essential for 
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several hippocampal-dependent forms of memory (Fuchs et al., 2007; Reisel et al., 2002; 
Sanderson et al., 2009). Since BCAN regulates GluA1 at excitatory synapses contacting 
PV+ cells (Figure 6), we next examined how the loss of BCAN affects learning and 
memory (Figures 8 and S8). We assessed spatial working memory on the T-maze and 
found a moderate impairment in Bcan mutant mice (Figures 8A and 8B) that resembles 
the phenotype of mice lacking GluA1 in PV+ cells (Fuchs et al., 2007). 
GluA1 mutants also exhibit impaired short-term spatial memory (Sanderson et al., 
2007). To assess whether the lack of BCAN leads to a similar phenotype, we used a 
novelty preference test on the Y-maze (Figures 8C-H and S8E-S8L) (Sanderson et al., 
2007). As expected, control mice showed a strong preference for the novel arm (Figures 
8E-7H). In contrast, Bcan mutant mice were incapable of discriminating between familiar 
and novel arms (Figures 8E-8H). Interestingly, when tested for novelty preference after 
incremental training (Figures S8E-S8L), Bcan mutant mice preferred the novel to the 
familiar arm showing higher discrimination indexes than control mice (Figures S8K and 
S8L). 
In contrast to the short-term deficiencies, long-term memories seem to be enhanced in 
GluA1 mutants (Fuchs et al., 2007; Sanderson et al., 2009). Thus, we reasoned that 
alterations in GluA1 subunit mobility due to lack of BCAN might also alter memory 
consolidation. To explore this possibility, we designed a novel object recognition (NOR) 
protocol to consecutively assess the effect of BCAN deletion on short-term and long-term 
memories (Figure 8I-8M and S8M-N). After a short retention interval, we observed that 
while control mice preferred the novel over the familiar object Bcan mutant mice devoted 
similar time to exploring both novel and familiar objects (Figures 8J, 8K). In contrast, 
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Bcan mutants were able to remember the familiar object after a longer retention time and 
spent more time exploring the novel object (Figure 8L). Interestingly, the discrimination 
index was higher in Bcan-/- mice than in controls (Figure 8M), suggesting potentially 
enhanced long-term memory in absence of BCAN. 
Since BCAN expression in astrocytes may contribute to the synaptic phenotype found 
in Bcan-/- mice (Figure 1), we next investigated whether the specific depletion of BCAN 
in PV+ cells was sufficient to cause short-term memory defects as observed in Bcan 
mutant mice. PV-Cre mice were injected at P12 with Cre-dependent shBcan- or control 
YFP-expressing viruses into the dorsal hippocampus and spatial short-term memory was 
assessed at P60 by the novelty preference test (Figures 8C, 8D, 8N-8Q and S8O-S8S). 
We found that Bcan knock-down mice displayed the same short-term memory deficit 
exhibited by Bcan mutant mice (Figures 8E-8H and 8N-8Q), demonstrating that normal 
levels of BCAN specifically in PV+ cells are required for short-term memory. Altogether, 
these results demonstrate that BCAN regulates plasticity-dependent events that are 
essential for learning and memory. 
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DISCUSSION 
Several of studies have revealed a critical role for PNNs in experience-dependent 
plasticity, learning and memory (Gogolla et al., 2009; Pizzorusso et al., 2002). However, 
how PNNs regulate the function of PV+ interneurons has remained enigmatic. Here we 
demonstrate that the PNN protein BCAN is expressed by a large fraction of PV+ cells. 
Expression of BCAN confers PV+ interneurons with specific synaptic and firing 
properties through the direct regulation of AMPARs and voltage-gated potassium 
channels. The levels of BCAN vary in response to changes in network activity that are 
required for learning and memory. Consistently, loss of BCAN leads to deficits in spatial 
working memory and short-term memory. These results demonstrate that the PNN 
protein BCAN orchestrates a dedicated molecular program that dynamically gates the 
drive of PV+ cells and underlies learning and memory. 
Since the extracellular matrix (ECM) influences cell-cell interactions, it is conceivable 
that specific components of the ECM may promote cellular and synaptic plasticity in a 
cell-specific manner. ECM molecules and associated proteins have been shown to 
regulate receptor clustering and shape synaptic differentiation, function and plasticity 
(Chang et al., 2010; Frischknecht et al., 2009; de Wit et al., 2013). In this study, we have 
shown that PV+ interneurons expressing BCAN receive more glutamatergic inputs than 
similar cells lacking BCAN. Specifically, expression of the GPI-anchored isoform of 
BCAN by PV+ cells is responsible for regulating the density of their excitatory synapses. 
In addition, release of BCAN2 from astrocytes may also contribute to synapse maturation 
onto PV+ cells. While astrocytes are well-known to critically regulate the development of 
glutamatergic inputs onto pyramidal neurons (Clarke and Barres, 2013), our results hint 
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at a possible role for these cells at the excitatory synapses of the PV+ interneurons. 
Future studies will need to address their function on interneuron wiring in more detail. 
Intriguingly, although our findings show a distinct function for BCAN1 and BCAN2 at 
the synapses, both BCAN isoforms are able to shift PV levels. One conceivable 
explanation is that the levels of the calcium binding protein PV change in response to 
different mechanisms: modifications in both the excitatory drive of PV+ cells that may 
affect intracellular calcium concentration and in the diffusion of local extracellular 
calcium. Consistently, PNNs are highly negatively charged and have been proposed to 
function as a buffering system for cations surrounding fast-firing neurons (Brückner et 
al., 1993). 
BCAN affects excitatory synaptic differentiation, at least in part by modulating the 
levels of GluA1 receptor at the synapse. In absence of BCAN, GluA1 fails to cluster in 
postsynaptic densities and this seems to cause a loss of excitatory synaptic contacts onto 
PV+ interneurons. Since the specific depletion of GluA1 from PV+ cells causes a similar 
phenotype, it is unlikely that the reduction in GluA1 observed in Bcan mutants is due to 
the loss of synapses by a GluA1-independent mechanism. Nevertheless, it is conceivable 
that other proteins interacting with BCAN also contribute to the synaptic phenotype 
described in the present study. Further studies will be needed to elucidate the contribution 
of other BCAN partners to the maturation of these synapses. 
BCAN identifies a dynamic population of PV+ interneurons that not only receives 
more excitatory synapses but also has distinctive intrinsic properties. PV+ cells 
expressing BCAN are less excitable, but they are more efficient once recruited. 
Consistently, we observed deficits in the Kv1.1 and Kv3.1b channels in absence of BCAN. 
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Worth mentioning, in Bcan mutants, homeostatic adaptations of PV+ interneurons in 
response to the decreased number of excitatory inputs seem to trigger changes in Kv1.1. 
Conversely, a cell-autonomous decrease in Kv1.1 has been previously shown to cause 
homeostatic changes in connectivity (Dehorter et al., 2015). Altogether, these data 
support a novel interesting notion that connectivity and cell excitability are reciprocally 
regulated at the circuit level. Nevertheless, ECM molecules have been implicated in 
synaptic plasticity through the regulation of ion channels (Kochlamazashvili et al., 2010). 
As such, BCAN may directly regulate ion channel density, position or function. Indeed, 
the changes in spike shape and Kv3.1b clustering appear more directly related with the 
absence of BCAN. Specifically, these properties seem to depend on BCAN expression in 
PV+ interneurons, as the PV+ cell-specific knock-down revealed a particularly strong and 
broad phenotype when compared to the full Bcan knock-out that might be explained by 
the different timing of the experimental manipulations. The mature fast-spiking (FS) 
properties of PV+ interneurons emerge gradually over the first postnatal weeks and are 
ultimately determined by elaborate interactions among the complements of ion channels 
that they express (Okaty et al., 2009). Likewise, the first PNNs are observed around P7 
and their maturation continues until P28 (Schweizer et al., 1993). In Bcan mutant cells, 
the absence of BCAN during this maturational progression may lead to the compensatory 
activation of parallel gene expression programs, including the previously reported 
Neurocan up-regulation (Brakebusch et al., 2002). In Bcan knock-down cells, however, 
BCAN downregulation takes place after the emergence of most of their mature FS 
physiological features, therefore missing the precise time window for a potential 
compensation. The presence of developmental adaptations in Bcan mutant PV+ cells, 
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might also explain why the relatively late expression of Bcan1 or Bcan2 is unable to 
rescue the electrophysiological phenotype. A complementary explanation is that the 
presence of both BCAN isoforms is required for PV+ cells to have normal intrinsic 
properties. Future work addressing the consequences of an earlier Bcan deletion and 
rescue, as well as the developmental emergence of FS properties in Bcan mutant PV 
cells, will help to further decompose the complex electrophysiological phenotype 
displayed by Bcan deficient PV cells. 
Growing evidence over the last two decades has shown that the synaptic expression of 
GluA1 is regulated by activity. For instance, activity-dependent AMPAR insertion at the 
synapse is the substrate for the expression of the synaptic scaling (Turrigiano, 2012). 
Interestingly, it was reported that the expression of CSPG proteins requires normal 
patterns of neural activity (Lander et al., 1997). In the present study, we have shown that 
BCAN expression is up- or downwardly scaled in response to activity changes. Cortical 
networks are dynamically regulated by activity in vivo (Donato et al., 2013), but little is 
known about how neurons sense and adapt to the dynamics alterations in network activity 
at the level of synapses and spiking properties. Recent studies have shown that some of 
these changes might be mediated by transcription factors (Bloodgood et al., 2013; 
Dehorter et al., 2015), but the mechanisms through which external signals directly control 
this process have remained elusive. Here we expose a novel molecular mechanism that 
simultaneously mediates modifications in the intrinsic properties and synaptic inputs of 
PV+ interneurons and that is regulated by experience. 
Our data provide evidence that BCAN, one of the major components of PNNs, allows 
PV+ cells to adapt their responses to different types of sensory experience. Specifically, 
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BCAN plays a crucial role in spatial working memory and short-term episodic-like 
memory but is dispensable, if not obstructive, for long-term memory. How do assemblies 
of neurons encode and represent different types of memory? It is worth mentioning that 
BCAN is enriched in the soma and proximal dendrites of PV+ cells, suggesting that it 
might regulate specific inputs arriving to PV+ cells. Indeed, in the hippocampus, different 
inputs have distinct subcellular specificity (Klausberger and Somogyi, 2008) and are 
involved in different aspects of memory (Kitamura et al., 2015). Experience could 
therefore drive context-specific activation of BCAN+/PV+ cells, where BCAN would 
contribute to strengthen their excitatory inputs and filter weak and asynchronous stimuli. 
This positive feedback loop might thus promote the synchronization of pyramidal 
neurons leading to the formation of short-term memories. On the contrary, prolonged 
sensory experience, such as that linked to an enriched environment, would attenuate the 
levels of the PNN protein BCAN. As a consequence, the excitatory drive onto PV+ 
interneurons would be reduced, further releasing pyramidal cells from inhibition and 
triggering the plastic rearrangements in the principal cell network that underlie memory 
consolidation. 
A growing amount of research is aiming to reveal the relationship between PNNs, 
memory and cognition (Tsien, 2013). The newly discovered function of BCAN in PV+ 
cell plasticity may represent a general principle through which activity-regulated PNN 
proteins orchestrate selective modifications in specific classes of neurons, thereby 
influencing network plasticity outcomes upon changes in the environment. 
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FIGURE LEGENDS 
Figure 1. Characterization of BCAN expression in the hippocampus at P30.  
(A-D) Identification of cell types expressing Bcan mRNA. (A-C) PV+ cells, astrocytes 
and oligodendrocytes among Bcan+ cells and percentage (D). Bcan common probe for 
both Bcan isoforms, Bcan1 and Bcan2 for secreted and membrane-bound isoforms, 
respectively (n = 3 mice). 
(E-G) PV+ cells expressing either (Bcan1/Bcan2) or both Bcan isoforms (Bcan) (E and 
F) and its percentage (G). The diagram in (G) is interprets the data in the bar graph (n = 3 
mice). 
(H and I) PV+ cells wrapped by BCAN protein (H) and percentage (I) (n = 3 mice). 
(J) Image of high-PV BCAN+ and low-PV BCAN- cells.  
(K) Cumulative probability plots in BCAN+ (n = 42 cells, 4 mice) and BCAN-PV+ cells 
(n = 29 cells, 4 mice). Kolmogorov-Smirnov test. 
(L-N) VGlut1+ somatic inputs on PV+BCAN+ cells (M-N) and percentage (L) (n = 6 
mice). 
(O) BCAN+ PV+ cell (conventional wide-field) overlaid with three-color STORM image 
of BCAN, Bassoon and Homer1. (P) High-magnification images and thresholded masks 
of O showing single synapses. 
(Q) Distribution of BCAN along the trans-synaptic axis. Analysis of 37 side-view 
synapses from 5 experiments. 
(R) Radial distribution of BCAN at the synapse. P(r)/r: probability density of localization 
at the radial position r. Analysis of 52 face-view synapses from 6 experiments. 
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Full and open arrowheads show colocalization and no colocalization, respectively. Data 
are presented as mean. In this and all subsequent figures, error bars represent SEM. Scale 
bars equal 10 µm (A-D), 20 µm (E, F, H), 5 µm (J and M), 1 µm (N), 2 µm (O), 250 nm 
(P). 
See also Figure S1. 
 
Figure 2. BCAN expression segregates subpopulations of PV+ cells. 
(A and B) High magnifications and thresholded masks (A’, B’) showing 
VGlut1+PSD95+ somatic synapses on the soma of BCAN+ (A) and BCAN- (B) PV+ 
cells (arrowheads). In A’ and B’ and all subsequent similar images, the opacity of the 
soma (dotted line) has been reduced to better visualize the synapses. 
(C) Density of VGlut1+PSD95+ somatic synapses on BCAN+ and BCAN- PV cells (n = 
7 mice). 
(D-G) Images and firing traces for BCAN+ (D and E) and BCAN- (F and G) PV+ cells. 
(H) inset from (E) and (G). NB, Neurobiotin. 
(I-M) Intrinsic properties of BCAN+ (n = 22 cells, 9 mice) and BCAN- (n = 13 cells, 9 
mice) PV+ cells. AP: Action potential; fAHP: fast after hyperpolarization; Max FF: 
Maximum firing frequency. Student t-test except for (I) and (K) where Mann-Whitney 
test was used. In this and subsequent figures *p < 0.05, **p < 0.01, ***p < 0.001, n.s., p 
> 0.05. Scale bars equal 1 µm (A, B), 5 µm (D, F). 
See also Figure S2 and Table S1. 
 
Figure 3. Deletion of BCAN changes inputs and properties of PV+ cells. 
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(A-D) Schematic, images, thresholded mask and density of somatic VGlut1+PSD95+ 
synapses (arrowheads) on PV+ cells (n = 6 WT, 5 Bcan-/-). 
(E-I) Traces, frequency, amplitude, rise and decay time of mEPSCs in WT (n = 12 cells, 
4 mice) and Bcan-/- PV+ cells (n = 16 cells, 3 mice). 
(J-L) Images (J and K) and cumulative probability plots (L) of PV fluorescence intensity 
in WT (n = 147 cells, 4 mice) and Bcan-/- (n = 164 cells, 4 mice). 
(M) Density of PV+ cells in the CA1 region of the hippocampus in WT (n = 6) and Bcan-
/- (n = 4) mice. 
(N-U) Intrinsic properties (N-P, R), cumulative probability plot for the spike latency (Q) 
comparing WT (n = 63 cells, 10 mice) and Bcan-/- (n = 41 cells, 6 mice) PV+ cells, firing 
traces for WT (S) and Bcan-/- (T) PV+ cells. (U) inset from S and T. 
(V) I/O curves showing the spike frequency of WT (n = 63 cells, 10 mice) and Bcan-/- (n 
= 41 cells, 6 mice) PV+ cells in response to current injections. 
Student t-test (D, F, G, I, O and R), Mann-Whitney test (H, M, N and P), Kolmogorov-
Smirnov test (L and Q), and two-way ANOVA (V). Scale bars equal 1 µm (B, C), 20 µm 
(J, K). 
See also Figure S3 and Table S1. 
 
 Figure 4. Cell-autonomous role of BCAN in PV+ cells. 
(A) Schematic of AAVs injections in the hippocampus of P12 PV-Cre mice. 
(B and C) mCherry and YFP from sparse infection and reduction of endogenous BCAN 
in shBcan-expressing PV+ mCherry+ (full arrowheads) but not mCherry- cells (open 
arrowheads). 
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(D) Schematic of BCAN knock-down (KD) PV+ cells in a WT background. 
(E-G) Density, images and thresholded masks of VGlut1+PSD95+ somatic synapses on 
WT (n = 22 cells, 3 mice) and shBcan (n = 23 cells, 3 mice) PV+ cells. 
(H) Cumulative probability plots (WT, n = 87 cells, 3 mice and shBcan PV+ cells, n = 35 
cells, 3 mice). 
(I-L) Images and firing traces for WT (J, same as in Figure 3S) and BCAN KD (I and K) 
PV+ cells. (L) inset from (J) and (K). NB, Neurobiotin. 
(M-U) Intrinsic properties and cumulative probability plot for spike latency comparing 
WT (n = 63 cells, 11 mice) and shBcan KD (n = 22 cells, 4 mice) PV+ cells. 
Student t-test (E, N, Q, S and U), Mann-Whitney test (M, O, R and T), Kolmogorov-
Smirnov test (H and P). Scale bars equal 100 µm (B), 20 µm (C), 1 µm (F, G), 10 µm (I). 
See also Figure S4. 
 
Figure 5. Specific roles for Bcan isoforms in PV+ cells and astrocytes. 
(A-C) Schematic of AAVs injections (A) and images showing YFP and BCAN1-HA (B) 
or BCAN2-HA (C). 
(D) BCAN1-HA overexpressing cell. 
(E-G) Images (E and F) and density (G) of VGlut1+PSD95+ somatic synapses onto Bcan-
/- (n = 40 cells, 5 mice) and BCAN1 rescued (n = 40 cells, 5 mice) PV+ cells. 
(H) Cumulative probability plots (Bcan-/-, n = 155 cells, 4 mice and BCAN1 rescued, n = 
127 cells, 4 mice). 
(I) BCAN2-HA overexpressing cell. 
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(J-L) Images (J and K) and density (L) of VGlut1+PSD95+ somatic synapses on Bcan-/- 
(n = 50 cells, 4 mice) and BCAN2 rescued (n = 34 cells, 4 mice) PV+ cells. 
(M) Cumulative probability plots (Bcan-/-, n = 98 cells, 3 mice and BCAN2 rescued, n = 
41 cells, 3 mice). 
(N-T) Schematic of AAVs injections (N) and images (O-T) showing CreGFP expression 
in astrocytes and BCAN1-HA (Q) or BCAN2-HA (S) in the surrounding tissue. P, R and 
T: high magnification images showing only CreGFP or BCAN1 or BCAN2 accumulation 
around PV+ cells. 
(U-X) Images (U, V and W) and density of VGlut1+PSD95+ somatic synapses on PV+ 
cells in Bcan-/- mice infected with the control virus only (GFAP-CreGFP, n = 6 mice) or 
together with BCAN1 (n = 4 mice) or BCAN2 (n = 6 mice) virus. 
Mann-Whitney test (G, L), Kolmogorov-Smirnov test (H, M), One-Way ANOVA (X). 
Scale bars equal 100 µm (B, C, O, Q, S), 5 µm (D, I, P, R, T), 1 µm (E, F, J, K, U, V, W). 
See also Figure S5. 
 
Figure 6. BCAN controls AMPARs and Kv channels. 
(A) Co-IP blots from WT hippocampal lysates illustrating pull-down of AMPARs and 
BCAN (n = 3 mice). 
(B and C) Blots and quantification of GluA1 in synaptosomes (S), non-synaptic 
membranes (M), cytoplasm (C) and total homogenate (H) from Bcan-/- and WT mice (n = 
6-13 mice per genotype). 
(D) Three-color STORM images of BCAN, Bassoon and GluA1 at single synapses onto 
PV+ cells. 
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(E) Radial distribution of BCAN and GluA1 relative to Bassoon. Analysis of 117 face-
view synapses from 11 experiments. 
(F-J) Images and thresholded masks illustrating GluA1+ (full arrowheads) and GluA1- 
(open arrowheads) excitatory somatic synapses on WT, Bcan-/-, Bcan KD, BCAN1 and 
BCAN2 rescued PV+ cells. 
(K-M) Density of GluA1+ clusters at VGlut1+PSD95+ synapses onto PV+ cells in (K) 
Bcan mutants (n = 5 mice) compared to WT mice (n = 6 mice) and in the cell-
autonomous experiments: (L) Bcan KD (n = 23 cells, 3 mice) compared to WT cells (n = 
22 cells, 3 mice) and (M) BCAN1 (n = 42 cells, 5 mice) and BCAN2 rescued (n = 22 
cells, 5 mice) compared to Bcan-/- cells (n = 29 cells, 5 mice). 
(N-P) Density, images and thresholded masks of VGlut1+PSD95+ synapses (arrowheads) 
contacting PV+ cells in PV-Cre; GluA1 conditional mutants (n = 10 mice) compared to 
controls (n = 6 mice). 
(Q and R) Blots and quantification of Kv3.1b in WT (n = 5 mice) and Bcan-/- (n = 4 mice) 
hippocampal lysates. 
(S-U) Images and density of Kv3.1b clusters in (T) WT (n = 5 mice) compared to Bcan-/- 
(n = 6 mice) mice and in (U) Bcan KD (n = 13 cells, 3 mice) compared to WT cells (n = 
23 cells, 3 mice). 
(V and W) Blots and quantification of Kv1.1 in WT (n = 9 mice) and Bcan-/- (n = 5 mice) 
hippocampal lysates. 
(X-Z) Images and density of Kv1.1 clusters in (Y) WT (n = 5 mice) compared to Bcan-/- (n 
= 5 mice) mice and in (Z) Bcan KD (n = 11 cells, 3 mice) compared to WT cells (n = 25 
cells, 3 mice). 
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Student t-test (C, K, L), one-way ANOVA (M), Mann-Whitney test (N, R, T, U, W, Y, 
Z). Scale bars equal 500 nm (D), 1 µm (F-J, O, P, S, X). 
See also Figure S6. 
 
Figure 7. BCAN expression is dynamically regulated by activity. 
(A and B) Blots and quantification of BCAN levels in hippocampal cultures treated for 
48 hours with vehicle, Gabazine or Nifedipine (n ≥ 7 wells from 6 independent cultures). 
(C and D) Blots and analysis of BCAN protein in the hippocampus of epilepsy patients (n 
= 4) compared to controls (n = 4). 
(E) Cumulative probability plots (control, n = 44 cells, 3 mice; and trained mice, n = 79 
cells, 4 mice). 
(F and G) Images of BCAN levels in the hippocampus of mice trained for 4 days in the 
MWM and swimming controls. 
(H) Percentage of PV+ cells wrapped by BCAN after 4 days (n = 3 controls and 4 trained 
mice) and 10 days (n = 4 controls and 4 trained mice) of MWM. 
(I) Cumulative probability plots (control, n = 54 cells, 3 mice; and EE mice, n = 71 cells, 
3 mice). 
(J and K) Images of BCAN level in the hippocampus of mice housed in an EE (K) 
compared to controls (J). 
(L) Percentage of PV+ cells enwrapped by BCAN in control (n = 5 mice) and EE mice (n 
= 3 mice). 
(M) Density of VGlut1+ somatic puncta on PV+ cells in control (n = 5 mice) and EE 
mice (n = 3 mice). 
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(N and O) Bcan1 and Bcan2 mRNA expression relative to that of GFAP in control (n = 5 
mice) and in mice housed in an EE for 4 (n = 5 mice) and 30 (n = 5 mice) days. Scale 
bars equal 15 µm (F, G, J, K). 
Mann-Whitney test (B, D, H, L, M), Kolmogorov-Smirnov test (E and I) and one-way 
ANOVA (N, O). 
See also Figure S7. 
 
Figure 8. BCAN deletion impairs working and short-term memory. 
(A) Schematic of the T-maze test. 
(B) Percentage of correct responses for wild type (WT, n = 8) and Bcan-/- (n = 10). 
(C and D) Schematic of the Y-maze test. 
(E-H) Number of entries (E), its discrimination index (DI) (F), total time spent (G) and its 
discrimination index (H) in the “familiar” and “novel” arms for WT (n = 10) and Bcan-/- 
(n = 10) mice. 
(I) Schematic of the novel object recognition test. 
(J and K) Analysis of short-time recognition memory in WT (n = 19) and Bcan-/- (n = 20). 
Time spent exploring the “familiar” and “novel” object (J). Discrimination index (K). 
(L and M) Analysis of long-time recognition memory in WT (n = 18) and Bcan-/- (n = 
16). Time spent exploring the “familiar” and “novel” object (L). Discrimination index 
(M). 
(N-Q) Number of entries (N), its discrimination index (DI) (O), total time spent (P), and 
its discrimination index (Q) in the “familiar” and “novel” arms for WT (n = 11) and Bcan 
KD (n = 13) mice in the novelty preference test. 
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Two-way repeated measures ANOVA (A). One-way ANOVA (E, G, J, L, N, P). Student 
t-test (F, H, K, M, O, Q). See also Figure S8. 
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STAR	Methods 
Contact for Reagent and Resource Sharing 
Further information and requests for reagents may be directed to and will be fulfilled by 
the lead contact, Beatriz Rico (beatriz.rico@kcl.ac.uk). 
Experimental Model and Subject Details 
Mice 
Brevican-/- mice (Brakebusch et al., 2002), PV-Cre (Hippenmeyer et al., 2005), PV-
Cre;GluA1F/F (Fuchs et al. 2007), VIP-Cre, and RCE (Jackson Laboratories #010908 and 
#032037), were maintained in a C57B/6 background (Charles River Laboratories); 
Nkx2.1CreERT2 mice (Jackson Laboratories #014552) were maintained in a 129S2/SV 
background and GIN mice (Jackson Laboratories #003718) were maintained in a FVB/NJ 
background. All experimental procedures were performed on male mice, except for the 
analysis of synapse density in PV-Cre;GluA1F/F mice (Figures 6N and S6G) and of the 
intrinsic properties in Bcan knock-down PV+ cells (Figures 4I-4U) where mice of both 
sexes were used. Animals were maintained under standard, temperature controlled, 
laboratory conditions, or in an enriched environment with free access to colored tunnels, 
mazes, climbing materials, and running wheels. Mice were kept on a 12:12 light/dark 
cycle and received water and food ad libitum with the exception of the rewarded 
alternation test. Animal procedures were approved by ethical committees (IN-CSIC and 
King’s College London) and conducted in accordance with Spanish and European 
regulations, and Home Office personal and project licenses under the UK Animals 
(Scientific Procedures) 1986 Act. 
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Method Details 
Perfusions and Immunohistochemistry 
Animals were deeply anesthetized with sodium pentobarbital by intraperitoneal injection 
and then transcardially perfused with PBS followed by 4% paraformaldehyde (PFA) in 
PBS. Brains were dissected out and postfixed for two hours at 4°C, cryoprotected in a 
series of sucrose-PBS solutions overnight at 4°C. Then, tissue was sectioned at 40 µm on 
a sliding microtome (Leica). Free-floating brain sections were permeabilized by 
incubating with 0.2% Triton X-100 in PBS for 1 hour and then blocked for 3 hours (0.3% 
Triton X-100, 1% Normal Goat Serum and 5% BSA), followed by incubation with 
primary antibodies in 0.3% Triton X-100, 1% Normal Goat Serum and 2% BSA 
overnight at 4°C. The next day, brains were rinsed in PBS and incubated with the 
appropriated secondary antibodies for 2 hours at room temperature, rinsed in PBS, and 
then incubated with DAPI. The following primary antibodies were used: mouse anti-
parvalbumin (1:1000, Sigma #P-3088), rabbit anti-parvalbumin (1:2000, Swant #PV-25); 
goat anti-parvalbumin (1:500, Swant #PVG-214); chicken anti-parvalbumin (1:500, SySy 
#195 006); guinea-pig anti-VGlut1 (1:2000, Millipore #AB5905), mouse anti-PSD95 
(1:500, NeuroMab #70-028), guinea-pig and rabbit anti-Brevican (1:1000, a gift from R. 
Frischknecht), rabbit anti-GluA1 (1:1000, Millipore #04-855), mouse anti-HA (1:500, 
Covance #MMS-101P), rabbit anti-DsRed (1:500, Clontech #632496), anti-GFP (1:1000, 
Aves Lab #1020), mouse anti-GAD65 (1:500, Millipore #MAB351R), mouse anti-
Synaptotagmin-2 (1:1000, ZFIN #ZDB-ATB-081002-25), goat anti-CB1 (1:400, Frontier 
Institute # CB1-Go-Af450), mouse anti-gephyrin (1:500, Synaptic Systems #147 011), 
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mouse anti-Kv3.1b (1:1000, NeuroMab #75-041), mouse anti-Kv1.1 (1:500, NeuroMab 
#75-007). 
Fluorescent In Situ Hybridization Histochemistry 
For dual-color fluorescent in situ hybridization combined with immunohistochemistry, 
mice were perfused and brains were fixed overnight in 4% PFA in PBS followed by 
cryoprotection in 30% sucrose-RNase free PBS. 30 µm sliding microtome sections were 
mounted on RNAse-free SuperFrost Plus slides (Fisher Scientific) with PBST 
(0.5%Tween20 in PBS), allowed to dry and postfixed in 4% PFA for 5 minutes. After 
three rinses with PBST, sections were treated with 5 µg/ml proteinase K in PBST 
(Invitrogen) for 5 minutes, briefly transferred to 4% PFA, and rinsed with PBST. 
Sections were then incubated for 1 hour at 62°C with hybridization solution (50% 
formamide, 10% dextran sulfate, 0.2% tRNA, 4% Denhardt’s solution, 200 mM NaCl, 10 
mM Tris, 5 mM NaH2PO4, 5 mM Na2HPO4, 5 mM EDTA, pH 7.5) and hybridized 
overnight at 62°C with 0.2-0.5 µg of digoxigenin (DIG)-labeled probes diluted in 
hybridization solution. The next day, sections were rinsed with 50% formamide, 0.5× 
SSC, and 0.5% Tween 4x30 minutes at 62°C and 1x30 minutes at room temperature. 
Sections were then blocked for 1 hour in 3% BSA, 20% blocking solution (Roche), 10% 
sheep serum in MABT (0.1 M maleic acid, 0.2 M NaOH, 0.2 M NaCl, 0.5% Tween) 
followed by incubation overnight at 4°C with anti-DIG antibody (1:5000; Roche) 
together with primary antibodies diluted in blocking solution. On the following day, 
sections were rinsed 12x15 minutes in MABT, incubated with secondary antibodies for 2 
hours at room temperature, rinsed 6x5 minutes in PBS, and incubated with DAPI. 
Sections were then rinsed twice with detection buffer (Tris HCl 100mM, 100 mM NaCl 
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5M, 10 mM MgCl2 pH 8) and incubated for 3 hours at room temperature in the dark with 
2-hydroxy-3-naphthoic acid 2'-phenylanilide phosphate (HNPP)/Fast Red mix (Roche) 
diluted 1:100 in detection buffer. Sections were rinsed with PBS-EDTA buffer, briefly 
transferred to 4% PFA, and rinsed twice with PBS. Then, sections were allowed to dry 
and covered with Mowiol/DABCO. Images were acquired in the following two days on 
an inverted Leica TCS-SP8 confocal with a 40x objective. The following DIG-labeled 
probes were used: Bcan (IMAGE: 5695027), Bcan1 (primers: 5’-
TGCACCCCTGAGGAGCAAGAC-3’ and 3’- CGGGTAAAACCTGAGGCCC 
TTGTG-5’) and Bcan2 (primers: 5’- GTAATTCTGCTGAAGGCTCAA-3’ and 3’-
TGGGTACAAAGCAGTTTAATACAG-5’). The probes used to detect the specific Bcan 
isoforms were obtained by RT-PCR amplification of P30 mouse hippocampal cDNA. 
The purified PCR product was A-tailed and cloned into the pGEMT-easy vector 
(Promega). The following primary antibodies were used: rabbit anti-parvalbumin (1:500, 
Swant #PV-25), rabbit anti-Olig2 (1:250, Millipore #AB9610), mouse anti-GFAP (1:500, 
Sigma #G3893). 
Super-Resolution Image Acquisition and Analysis 
For super-resolution imaging, mouse brains were fixed overnight in 4% PFA in PBS and 
cryoprotected in 30% sucrose-PBS. 20 µm sliding microtome sections were stained 
following immunohistochemistry procedure. The following primary antibodies were 
used: guinea-pig anti-Brevican (1:1000, a gift from R. Frischknecht), mouse anti-Bassoon 
(1:500, Abcam #ab82958), rabbit anti-Homer1 (1:400, Synaptic Systems #160 002), 
rabbit anti-GluA1 (1:1000, Millipore #04-855).  
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Image Acquisition Single-molecule localization microscopy was performed on a custom-
built setup as previously described (Platonova et al., 2015). In brief, a 473 nm laser 
(100 mW, Laserglow Technologies) was used for activation and a 643 nm laser 
(150 mW, Toptica Photonics) for imaging. Both lasers were focused onto the back-focal 
plane of an Olympus NA 1.49, 60x, TIRF-objective. A quad-edge dichroic beamsplitter 
(405/488/532/635 nm, Semrock) was used to separate fluorescence emission from 
excitation light. Emission light was filtered by two bandpass emission filters (700/75 nm, 
Chroma) and a long pass dichroic beamsplitter (690 nm, AHF Analysetechnik) was used 
to split the emission light. The emission was dually focused by two separate 500 mm tube 
lenses and onto a back-illuminated EM-CCD chip (Evolve, Photometrics) which was 
liquid-cooled to -80°C. Focusing was done by moving the objective with a piezo 
objective positioner (MIPOS100, Piezo Systems Jena). A focus lock was implemented by 
an electronic feedback loop (LabView, National Instruments), based on total internal 
reflection of a red laser at the cover slip and its detection on a quadrant photodiode. The z 
stability was better than ±10 nm over several hours. For SMLM imaging, the switching 
buffer consisted of 0.1 M MEA/0.2 M Tris, pH 8.0 with 5 % (w/v) glucose, 0.25 mg/ml 
glucose-oxidase and 20 µg/ml catalase. The imaging laser intensity of the 643 nm laser 
line used was ~2 kW/cm 2. To keep the average number of localizations per frame 
constant (maximum intensity ~0.5 kW/cm2), the intensity of the 473 nm activation laser 
was automatically adjusted. Imaging was performed in objective-type total internal 
reflection fluorescence (TIRF) mode. We recorded a minimum of 30,000 frames with an 
exposure time of 20-35 milliseconds. All data analysis was performed in MATLAB 
(Mathworks). The acquired raw camera frames were filtered using a running median 
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filter, a 50 frame filter radius and a keyframe separation of 20 frames. Single-molecule 
positions were determined by Gaussian fitting based on a maximum likelihood estimator 
and only localizations with a maximum localization precision of 15 nm and a maximum 
PSF of 180 nm (1/e-intensity) were considered for further analysis. An image-correlation 
based drift-correction was employed. The first 25 frames of the dSTORM acquisition 
were used for a coarse estimate of the translational shift between the left and right side of 
the EMCCD chip. This was done using the phase difference of the Fast Fourier 
Transform, which was calculated using a pixel-reconstructed image from the single-
molecule localization coordinates using a pixel-size of 100 nm. The localizations from 
the short-wavelength channel were coarsely mapped onto the localizations of the long-
wavelength channel and paired. For pairing the localizations of the two channels in each 
frame had to be within a maximum search-radius of 8 camera pixels (~800 nm). The 
paired localizations were used to calculate an affine transformation matrix using the 
MATLAB built-in routine cp2tform. The transformation matrix was used to map the 
localizations from the short-wavelength onto the localizations of the long-wavelength 
channel. The overall registration precision was 25-35 nm. The localizations were paired 
again, but using a more stringent cut-off of 1 pixel for the search-radius. The normalized 
intensity ratio was calculated for all localization pairs for the color-assignment using 
r=(Il−Is)/(Il+Is), where Il and Is are the fluorescence intensities determined by maximum-
likelihood fitting for the long and short wavelength channels, respectively. The 
localization pair was assigned to AF647, CF660C or C680 by manually selecting the 
ranges for the normalized intensity ratio. Examples for the dye separation are provided in 
Figure S1. 
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Data analysis. Individual synapses contacting the soma of PV cells were manually 
selected from three-color dSTORM images. To determine the distribution between pre- 
and post-synaptic site (Figure 1M), “side” view synapses were chosen such that Bassoon 
and Homer1 were seen as parallel stripes. A line along the center of the pre-synaptic 
Bassoon was drawn manually (position = 0 nm). The synapses were overlaid with 
Bassoon = 0 and Homer1 was used to determine the orientation of the synapse. The 
longitudinal profile of Bassoon/Brevican/Homer1 across the synapse was then 
determined straightforwardly. For the radial distribution analysis of 
Bassoon/Homer1/Brevican (Figure 1N) and Bassoon/GluA1/Brevican (Figure 5H), 
“face” view synapses were chosen such that Bassoon/Homer1 and Bassoon/GluA1 were 
seen as overlapping round or elliptical discs. The mean x,y position of the Bassoon 
localizations of each synapse (simplified and considered to be radially symmetric) was 
set to x,y = 0,0. The Euclidian distance of the Bassoon/Homer1/Brevican and 
Bassoon/GluA1/Brevican localizations was used to compute their radial distribution for 
each synapse. The two-color radial distribution analysis of Brevican with respect to 
Bassoon (Figure S1R) or Homer1 (Figure S1S) was done correspondingly, except that in 
the latter case the mean x,y position of Homer1 localizations was used to establish x,y = 
0,0. 
Cell Culture, Transfection, Pharmacology and Immunocytochemistry 
Cell line cultures. HEK293FT cells were cultured in Dulbecco’s Modified Eagle’s 
medium supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (50 
units/ml) and streptomycin (50 g/ml). The cultures were incubated at 37°C in a 
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humidified atmosphere containing 5% CO2. HEK293FT cells were transfected using 
polyethylenimine (PEI, Sigma) at a 1:4 DNA:PEI ratio.  
Primary hippocampal cultures. Hippocampi from E18 mouse embryos (both sexes) 
were dissected in ice-cold Hank's Balanced Salt Solution (HBSS), digested with 1 mg/ml 
trypsin (Worthington) for 15 minutes at 37°C, treated with 0.1 mg/ml DNase I (Roche) 
and triturated to produce a single cell suspension. Cells were then plated at 100,000 
cells/cm2 on plastic dishes. Cells were cultured in Neurobasal (Invitrogen) supplemented 
with 2% B27 (Invitrogen), glutamine (2 mM) and 100 µg/ml penicillin-streptomycin 
(Gibco). For in vitro activity manipulations, 26DIV neuronal cultures were treated for 48 
hours with 20 μM Gabazine or 20 μM Nifedipine, or their appropriated controls (H2O, 
and DMSO, respectively).  
Immunocytochemistry. HEK293FT cells were fixed in 4% PFA/1% sucrose in PBS for 
10 minutes, briefly washed in PBS and permeabilized with 0.2% Triton X-100 in PBS. 
Coverslips were blocked with 5% BSA in PBS for 1 hour and incubated with primary 
antibodies in blocking solution overnight at 4°C. Coverslips were then washed 6x5 
minutes in PBS and incubated with secondary antibodies in blocking solution for 1h at 
room temperature. Coverslips were then washed 6x5 minutes in PBS, incubated with 
DAPI and mounted in Mowiol/DABCO. Primary antibodies used: chicken anti-GFP 
(1:3000, Aves Lab #1020), guinea-pig anti-Brevican (1:2000, a gift from R. 
Frischknecht), rabbit anti-Brevican (1:2000, a gift from R. Frischknecht), rabbit anti-
DsRed (1:500, Clontech #632496), mouse anti-HA (1:500, Covance #MMS-101P). 
Generation of AAV Expression Vectors 
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To generate the pDIO-shBCAN-mCherry, the sequence containing the distal and proximal 
elements of the U6 promoter spaced by the CDS for mCherry was amplified by PCR. The 
resulting PCR product was cloned into the pAAV-EF1a-DIO-mCherry vector (a gift from 
Prof. K. Deisseroth, Addgene plasmid #20299) and a TATA box was introduced in the 
U6 fragment (primer sequences and cloning details will be provided elsewhere). The 
ssDNA primers to generate the shBCAN (5’-
CTAGGCAAGCAGAACCGCTTCAATGCCTGACCCACATTGAAGCGGTTCTGTT
GCTTTTTG-3’ and 3’-AATTCAAAAAGCAAGCAGAACCGCTTCAATGTGGGTC 
AGGCATTGAAGCGGTTCTGCTTGC-5’) were obtained using the Block-it RNAi web 
tool (Thermo Scientific). To minimize the putative off-target effects of the shRNA, a 
miR-133 derived loop sequence was used (Gu et al., 2012). Moreover, the shRNA 
sequence was blasted and no other mouse mRNA apart from Bcan was predicted to be 
targeted. The coding sequences for Bcan1 and Bcan2 full-length used in the rescue 
experiments were obtained from P30 mouse hippocampal cDNA and cloned into the 
pGEMT-easy vector (Promega). A canonical HA tag sequence was introduced after the 
signal peptide (primers: 5’-TCTAGAGCCACCATGATACCACTGCTTCTGTCCCT 
GCTGGCCGCTCTGGT-3’ and 3’-TTGGGTCAGGACCAGAGCGGCCAGCAGGGA 
CAGAAGCAGTGGTATCATGGTGGCCTAGAA-5’; 5’-CCTGACCCAAGCCCCTG 
CCGCCCTCGCTGATTACCCATACGATGTTCCAGATTACGCTAGATCTA-3’ and 
3’-AGATCTAGCGTAATCTGGAACATCGTATGGGTAATCAGCGAGGGCGGCA 
GGGGC-5’) and cloned in the pAAV-EF1a-DIO-mCherry vector. To generate a Bcan2 
mutant that lacks the GPI anchor (BCAN2-GPI), the DNA sequence coding for the 
protein region containing the C-terminal GPI-modification sites was removed from 
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Bcan2 full-length (PSSGNSAEGSMPAFLLFLLLQLWAT, best predicted site is shown 
in bold and is underlined, the alternative site is underlined). 
AAV Production and Intracranial Injections 
HEKs 293FT cells (ThermoScientific) were seeded on 15-cm plates and co-transfected 
with packaging plasmids AAV-ITR-2 genomic vectors (7.5µg), AAV-Cap8 vector pDP8 
(30µg; PlasmidFactory GmbH, Germany, #pF478) using PEI (Sigma) at a ratio 1:4 
(DNA:PEI). 72 hours post transfection, supernatants were incubated with ammonium 
persulfate (65g/200ml supernatant) for 30 minutes on ice and centrifuged for 45 minutes 
at 4000 RPM at 4°C. Transfected cells were harvested and lysed (150mM NaCl, 50mM 
Tris pH8.5), followed by three freeze-thaw cycles and Benzonase treatment (50U/ml; 
Sigma) for 1 hour at 37°C. Filtered AAVs (0.8 µm, 0.45 µm and 0.2 µm MCE filters) 
from supernatants and lysates were run on an iodixanol gradient by ultracentrifugation 
(Vti50 rotor, Beckmann Coultier) at 50,000 RPM for 1 hour at 12°C. The 40% iodixanol 
fraction containing AAV was collected, concentrated using 100 kDa-MWCO Centricon 
plus-20 and Centricon plus-2 (Merck-Millipore), aliquoted and stored at -80°C. The 
infectious titer of virus was measured by quantitative real-time PCR (primers: 5’-
GGCACTGACAATTCCGTGGT-3’ and 3’-CGCTGGATTGAGGGCCGAA-5’). AAVs 
with a titer equal or higher to 1011 genome copy/ml were used for in vivo injections. The 
AAV9-EF1a-DIO-eYFP was generated by and acquired from the Penn Vector Core, with 
a titer of 3.95 x 1013 genome copy/ml. The AAV8-GFAP(0.7)-EGFP-T2A-iCre was 
generated by and acquired from the Vector Biolabs, with a titer of 5.6 x 1013 genome 
copy/ml. 
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For intracranial injections, P12 mice were anesthetized with isoflurane and were 
mounted in a stereotactic frame. For synapse analysis, 250 nl of AAV8-shBcan-
mCherry:AAV9-YFP in a 10:1 ratio, AAV8-Bcan1-HA:AAV9-YFP in a 10:1 ratio, 
AAV8-Bcan2-HA:AAV9-YFP in a 10:1 ratio, AAV8-Bcan2-HA:AAV8-GFAP-iCRE in 
a 1:1 ratio or AAV8-Bcan2-HA:AAV8-GFAP-iCRE in a 1:1 ratio were unilaterally 
injected into the dorsal region of the left hippocampus (anteroposterior −2.8 mm; 
mediolateral +1.2 mm; dorsoventral −1.3 mm relative to Bregma) at an injection rate of 
50 nl/minute followed by 2 additional minutes to allow diffusion.  
For electrophysiology or behavioral experiments we performed injection of high titer 
Cre-dependent viruses. Specifically, 400 nl of AAV8-shBcan-mCherry:AAV9-YFP in a 
10:1 ratio, 400 nl of AAV8-Bcan1-HA:AAV9-YFP in a 10:1 ratio or 400 nl AAV8-
Bcan2-HA:AAV9-YFP in a 10:1 ratio (for electrophysiology experiments) or 500 nl of 
AAV8-shBcan-mCherry or 500 nl of AAV9-YFP (for behavioral experiments) were 
bilaterally injected into the dorsal region of the hippocampus (anteroposterior −2.5, −2.8, 
−3.2 mm; mediolateral +1.2 mm; dorsoventral −1.3 mm relative to Bregma) at an 
injection rate of 100 nl/minute. Post-recording immunocytochemistry was carried out to 
evaluate the recorded cell and/or the expansion of the injection. For behavior, the 
injections massively targeted the majority of the PV cells in the dorsal hippocampus (data 
not shown). 
Western blot and Fractionation 
For Western blot analysis on neuronal cultures, DIV28 E17.5 hippocampal cultures or 
HEK293FT were placed on ice and rinsed 1x in PBS. For Western blot analysis on mouse 
tissue, P30 hippocampi were rapidly dissected in ice cold PSB. Samples were 
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homogenized in lysis buffer containing 25 mM Tris-HCl pH 8, 50mM NaCl, 1% Triton 
X-100, 0.5% sodium deoxycholate, 0.001 % SDS and protease inhibitor cocktail. For 
anti-Brevican Western blot, samples were digested with 1.7U/mg of ChABC (Sigma) for 
2 hours at 37°C. For fractionation experiments, Syn-PER™ Synaptic Protein Extraction 
Reagent (ThermoScientific) or Subcellular Protein Fractionation Kit for Tissues 
(ThermoScientific) were used according to the manufacturer's instructions. Protein 
quantity was measured using bicinchoninic acid (BCA) assay (ThermoScientific). All 
samples were denatured, resolved by SDS-PAGE and transferred onto PVDF membranes. 
Membranes were blocked with 5% nonfat milk (Biorad) in TBST (20mM Tris-HCl 
pH7.5, 150mM NaCl and 0.1% Tween20) for 1 hour and probed with the following 
primary antibodies: mouse anti-PSD95 (1:500, NeuroMab #70-028), guinea-pig and 
rabbit anti-Brevican (1:1000, a gift from R. Frischknecht), rabbit anti-actin (1:1000, 
Sigma #A2066), rabbit anti-GluR1 (1:1000, Millipore #04-855), mouse anti-GAPDH 
(1:1000, Sigma # G8795), rabbit anti-T-cadherin (1:500, Millipore #ABT121), rabbit 
anti-Na,K-ATPase (1:1000, Abcam, #ab76020), mouse anti-HA (1:500, Covance #MMS-
101P), mouse anti-Kv1.1 (1:500, NeuroMab #75-007). After incubation with HRP-
conjugated secondary antibodies, protein levels were visualized by chemiluminescence. 
Blots were scanned using a LI-COR Odyssey® Fc Imaging System and band were 
quantified with Image Studio Software. For quantification, densitometry of protein bands 
of interest was normalized to that of actin. 
Co-immunoprecipitation Assays 
100 µg of hippocampal homogenates from P30 mice or, for Brevican isoform-specific 
Co-IP, 100 µg of hippocampal homogenates from P30 Bcan mutant mice were mixed 
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with 50 µg of lysate from HEK293FT co-transfected with CreGFP and a Cre-dependent 
Bcan1-HA or Bcan2-HA expressing plasmid were used. The lysate was then diluted in 1 
ml of Co-IP buffer (0.3M sucrose, 10 mM Tris-HCl pH 8, 10 mM NaCl, 3 mM MgCl2, 
1% NP-40, 5% glycerol and protease inhibitor cocktail) and subsequently incubated 
overnight at 4°C with 2 μg of one of the following antibodies: rabbit anti-GluR1 
(Millipore #04-855), rabbit anti-GluR2-3 (Millipore #AB1506), rabbit anti-GluR4 
(Millipore #AB1508), rabbit anti-NMDAR2B (Millipore #AB1557P), Rabbit IgG-
Isotype Control (Abcam #ab27478), rabbit anti-mGluR2-3 (Millipore #AB1553), mouse 
anti-Kv1.1 (NeuroMab #75-007), mouse anti-Kv3.1b (NeuroMab #73-041), Mouse IgG-
Isotype Control (Abcam # ab37355). 50 μl of protein A-Sepharose (Sigma) bead slurry 
was washed in Co-IP buffer and added to the mixture. After overnight incubation at 4°C 
with gentle rotation, the beads were pelleted and rinsed three times with Co-IP buffer. 
Immune complexes were then analyzed by western blot. 
In vitro Patch Clamp Recordings 
Slice preparation. Postnatal day (P) 26-38 mice were deeply anesthetized with sodium 
pentobarbital and transcardially perfused with ice-cold sucrose-based cutting solution 
containing (in mM): 70 Sucrose, 86 NaCl, 4 KCl, 1 NaH2PO4, 7 MgCl2, 26 NaHCO3, 25 
Glucose and 0.5 CaCl2. After brain dissection, 300 µm coronal hippocampal slices were 
cut using a vibratome (Leica) in the same ice-cold solution. After cutting, slices were 
transferred to an incubation chamber filled with artificial cerebrospinal fluid (ACSF) 
heated to 34 ˚C and containing (in mM): 127 NaCl, 2.5 KCl, 0.6 NaH2PO4, 26 NaHCO3, 
13 Glucose, 1.3 MgSO4, 2 CaCl2. Slices were kept in this heated chamber for 30 minutes 
and then transferred to a second chamber containing the same solution at room 
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temperature, where they were kept for an additional 30 minutes, and throughout the day, 
before recordings. 
Patch clamp recordings. After recovery, slices were transferred to a recording 
chamber continuously superfused with ACSF heated to 34 ˚C. PV interneurons were 
viewed with infrared-differential interference optics (Hamamatsu camera controller) and 
fluorescence illumination (Cool Led 473nm) through a 40x water-immersion objective 
(Olympus). Patch microelectrodes (4–8 MΩ) were pulled from borosilicate glass (1.5 mm 
outer diameter x 0.86 mm inner diameter; Harvard Apparatus) using a vertical P10 puller 
(Narishige). Current-clamp and voltage-clamp (sEPSC) recordings were performed using 
an intracellular solution containing, in mM, 130 KGluconate, 5 KCl, 10 HEPES, 2 
MgCl2, 10 Sodium Phosphocreatine, 2 Na2-ATP and 0.4 Na-GTP, as well as 1mg/ml 
neurobiotin. sEPSCs were recorded at a holding potential of -70 mV. During current-
clamp recordings, membrane potential was biased towards -65 mV. Cells were kept under 
current-clamp or voltage-clamp configuration with a Multiclamp 700B amplifier 
operating in fast mode. For mEPSC and mIPSC recordings, the following intracellular 
solution was used (in mM): 135 Cesium Methanesulfonate, 8 KCl, 10 HEPES, 0.4 Mg-
ATP, 2.0 Na2-ATP, 0.5 EGTA, 0.6 Na-GTP. 1 µM TTX was added to the bath. mEPSCs 
were recorded at -60 mV and mIPSCs at +10 mV, accounting for an estimated liquid-
junction potential of 10.4 mV. No pharmacological blockade of transmission was 
performed, in order to allow recording mEPSCs and mIPSCs from the same cell. Data 
were filtered on-line at 2 kHz, and acquired at a 20 kHz sampling rate for current-clamp 
recordings in Figure 2 and 50kHz for all others using pClamp 10.7.0 software (Molecular 
Devices). For immunohistochemistry after patch clamp recording, slices were 
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immediately drop-fixed in PFA 4% at room temperature for 30 mins and subsequently 
transferred into PBS with 0.05% sodium azide. For BCAN+ and BCAN- cells, only one 
cell was recorded per slice, as to allow for unequivocal identification between 
immunohistochemical staining and electrophysiological recording. 
Data analysis. Intrinsic properties were measured rapidly after obtaining whole-cell 
configuration, through injection of a series of depolarizing or hyperpolarizing 500 
milliseconds current steps were used at 0.5 Hz. Resting membrane potentials were 
measured just after patched membranes were ruptured by suction. Input resistance and 
membrane time constants were determined by passing hyperpolarizing current pulses 
inducing voltage shifts of 5-15 mV negative to resting membrane potential. Time 
constants were measured by fitting voltage responses with a single exponential function. 
Action potential (AP) threshold was determined as the voltage at which slope trajectory 
reached 20 mV/milliseconds. AP widths at half amplitude were measured for spikes 
elicited by depolarizing current pulses of threshold strength. Rheobase was determined by 
initially injecting positive current generating near-threshold 15-25 mV depolarizations 
and subsequently applying 1 pA current steps until APs were elicited. Rheobase was 
considered to have been reached once three such steps consecutively produced an AP, 
with the lowest value of the AP-generating injected currents used. Delay to first AP was 
measured during the same procedure, as the time elapsed between onset of current 
injection and AP threshold and was calculated from the average of 4 repetitions of this 
procedure. AP height was calculated as the difference in membrane potential between AP 
threshold and the peak. Afterhyperpolarisation (AhP) amplitude was defined as the 
difference between AP threshold and the most negative potential attained within 5 
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milliseconds of AP threshold. AhP time was defined as the time elapsed between this 
point and AP threshold. For Bcan-/- recordings, since a change in AP threshold occurred, 
we corrected AhP amplitude accordingly. Saturating firing frequency and input-output 
curves were obtained by injecting steps of 100 pA current and counting spike number. AP 
frequency adaptation was calculated as the percent change in spike frequency during the 
last 100 milliseconds of the spike train compared to the first 100 milliseconds. Synaptic 
currents were analysed semi-automatically with Mini-Analysis (Synaptosoft), using 
detection parameters of 7 pA for event threshold, 10 ms for searching for a local 
maximum, 5 ms to search for baseline before peak, 50 ms to search for decay time and 
0.37 as the fraction of peak amplitude to find a decay time. Rise-time was calculated as 
time elapsed between 10 and 90% of peak amplitude. 
Image Acquisition and Analysis 
Samples belonging to the same experiment were imaged during the same imaging session 
on an inverted Leica TCS-SP8 confocal. Imaging was performed with the same laser 
power, photomultiplier gain, pinhole and detection filter settings (1024x1024 resolution, 
12 bits or 16 bits). For cell co-localization analyses, confocal image stacks (40X oil 
immersion objective, 1.4 NA, 0.2 µm step size) were used to create maximum intensity 
projections and analyzed using a custom macro in Fiji (ImageJ) software. For Brevican 
and PV level analyses, Cy3 and AF647 fluorophores were used, respectively, and 
confocal image stacks (40X oil immersion objective, 1.4 NA, 0.2 µm step size) were 
reconstructed and analyzed with IMARIS 7.5.2 software. PV neurons whose soma was 
included within the tissue sections with optimal staining were isolated in three 
dimensions. Three-dimensional isosurfaces were created around each PV-neuron soma 
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using the “create surface” tool and volume and labeling intensities were quantified 
automatically. A threshold was selected to include as much of the neuron as possible 
while excluding any background. A size filter was applied with the minimum size being 
related to the volume of the PV cell. The PV surface was then used to define the cellular 
domain and create three-dimensional isosurfaces around the PV neuron in the Brevican 
channel. The threshold was selected so as to have no surface reconstruction outside the 
cellular domain of PV cells. Brevican volume and intensity were quantified 
automatically. For synaptic puncta/cluster analysis, images of z-planes with optimal 
staining of synaptic markers were acquired (100X oil immersion objective, 1.44 NA, 2.2 
digital zoom). Analysis of excitatory and inhibitory synapses contacting PV cells was 
carried out in the stratum oriens of the CA1 region of the hippocampus. Analysis of 
synaptic puncta/cluster densities was performed using a custom macro in Fiji (ImageJ) 
software. Processing of all channels included background subtraction, Gaussian blurring, 
smoothing and contrast enhancement. All single channel images were converted to RGB. 
For the PV soma, a color threshold was selected to identify the cell soma. The border of 
the soma was automatically or manually drawn to automatically calculate its perimeter 
and create a mask with the cell body only. For the presynaptic boutons or postsynaptic 
clusters, a color threshold was selected to include as many putative synapses as possible 
while excluding any background. The same threshold in each channel was applied to all 
images from the same experiment. The “Analyze Particles” (size 0.10-infinity, circularity 
0.00-1.00) and “Watershed” tools were applied and a mask was generated. A merged 
image from all masks was created. Presynaptic boutons were defined as such when they 
were located outside the perimeter border but had ≥ 0.1 µm2 colocalizing with the mask 
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of the soma. The criterion to define postsynaptic clusters was that ≥ 0.2 µm2 of the cluster 
area in the mask was located inside the perimeter border of the soma. Synapses were 
counted when an identified postsynaptic cluster was contacted by a presynaptic terminal 
(i.e. they had ≥ 1 pixel colocalizing) or when an identified presynaptic bouton was 
contacting (i.e. they had ≥ 1 pixel colocalizing) a postsynaptic cluster with ≥ 1/4 of its 
area located inside the perimeter border of the soma. For the four-color analysis of 
GluA1-containing synapses, GluA1 clusters in PV cells were considered located at the 
synapse when colocalising with a PSD-95 postsynaptic cluster that was contacted by a 
VGlut1 presynaptic terminal. For the correlation analysis shown in Figure S2B, confocal 
image stacks (100X oil immersion objective, 1.4 NA, 2.2 digital zoom, 0.2 μm step size) 
were reconstructed and analyzed with IMARIS 7.5.2 software. The PV cell soma was 
reconstructed with the “create surface” tool as described above. The VGlut1 presynaptic 
boutons and the Brevican coats were detected with the “spot” tool using a spot diameter 
of 0.68 µm for the VGlut1 boutons and of 0.5 µm for the Brevican coats. A threshold was 
selected to accurately detect as many spots as possible without creating artifacts. The 
radius of the spot was used as a threshold distance to define the contact and the “Find 
spots close to surface” tool (ImarisXT extension) was then used to count the number of 
presynaptic VGlut1 and Brevican spots that were contacting the surface of the soma. 
In utero electroporation and Tamoxifen Induction 
CA1 pyramidal cells were labeled by in utero electroporation of a GFP plasmid in NEX-
Cre mice. Pregnant females were anesthetized with isofluorane. The uterine horns were 
exposed and embryos were injected through the uterus wall using pulled capillaries filled 
with DNA (1.5 μg μl-1) diluted in PBS and colored with Fast Green (0.5%) (Sigma). 
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Brain ventricles were filled with DNA solution (pCAGGS-IRES-GFP or pCAGGS-CRD-
Nrg1-IRES-GFP) and electroporated (CUY21/CUY650P3/ CUY650P5, Nepa Gene Co.) 
using a program of 45 V, 50 ms, 950 ms, and five pulses. 
Tamoxifen was dissolved in corn oil (10 mg/ml) at 37°C with constant agitation. 
Chandelier cells (ChCs) were labeled by intra-gastric tamoxifen injections of P2 post-
natal Nkx2.1CreERT2;RCE mouse pups at a dose of 1mg/10g of body weight. 
Quantitative real-time PCR 
Total RNA was extracted from mouse hippocampi using TRIzol reagent (Invitrogen) 
followed by DNAse I treatment (Promega). cDNA synthesis was performed using the 
SuperScript IV First-Strand Synthesis System (Invitrogen) according to the 
manufacturer’s protocol. qPCR was carried out in triplicates on a LightCycler 480 
Instrument (Roche) using SYBR Green PCR Master Mix (Roche). Normalized mRNA 
levels for Bcan1 and Bcan2 relatively to those of Syt2 or Gfap were calculated using the 
comparative CT method. The sequences of qPCR primers were as follows: Bcan1 (Fw: 
CTATGTTTGCCAGGCTATGGGGG, Rv: TGCCTCCTCCCAACTCCTTCGTG), 
Bcan2 (Fw: GTCCTGGCAGGCACCTCAGTG, Rv: GCATTGAGCCTTCAGCAGAA 
TTAC), Syt2 (Fw: ACGTGCCCACAGCTGGGAAGCTC, Rv: GTCTCTTACCGTTCT 
GCATCAGG), Gfap (Fw: GGGACAACTTTGCACAGGACCTC, Rv: GGTGGCTTC 
ATCTGCCTCCTGTC). The activity-dependent gene Npas4 (Fw: TTCAAGCCAAG 
CATGGAGGCTGG, Rv: TAGCTGCTGGCGGAGGCTCC AGG) (Bloodgood et al., 
2013), was used to confirm the increase in activity in the enriched environment 
experiment. 
Epilepsy human samples 
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Frozen postmortem brain tissue from individuals with epilepsy and controls was kindly 
supplied by the MRC London Neurodegenerative Diseases Brain Bank. Brain tissue of 
both sexes and age between 54 and 80 years old was used in the study. Control brains 
were from individuals with no history of epilepsy or psychiatric disease. The use of 
human sections was covered by ethics approval granted to the London Neurodegenerative 
Diseases Brain Bank. For biochemical analysis, 50 µg of tissue from the CA1 region of 
the hippocampus were homogenized in lysis buffer and processed following Western blot 
procedures as described above. 
Behavioural procedures 
Animals were maintained under standard, temperature controlled, laboratory conditions 
and kept in 12 hours light-dark cycles with ad libitum access to food and water with the 
exception of the rewarded alternation test. For all behavioral tests, mice were housed 
singly and assessed during the light phase of the day. 
Enriched environment. C57BL/6J male mice were housed together for 4 days (8-week 
old mice) or 1 month (4-week old mice) in an enrichment cage composed of colored 
tunnels, mazes, climbing materials, and tilted running wheels (Marlau Cage, ViewPoint 
Behavior Technology). Controls were age-matched littermates housed in standard 
conditions. 
Morris Water Maze. Testing of 8-12 weeks old C57BL/6J (n = 10) was performed in a 
130-cm pool filled with milky water, surrounded by four different objects placed as 
reference cues onto white curtains. A circular escape platform (10 cm diameter) was 
submerged 0.5 cm below the water surface. Mice were trained to find the platform during 
four trials a day, with inter-trial intervals of 5 minutes spent in their home cage. During 
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training, mice were released from pseudo-randomly assigned start locations; they were 
allowed to swim for up to 60 seconds and they were manually guided to the platform in 
the case of failures. Performance was scored as the average latency to find the platform in 
the four consecutive trials each day. On the last day, the reference memory was assessed 
as fraction of time spent in the target quadrant during one full trial (60 seconds) upon 
removal of the escape platform. Swim controls (n = 8) were age-matched mice that were 
allowed to swim in the pool without escape platform, in a comparable training regime 
(four trials per day; inter-trial intervals of 5 minutes). For swim controls, trial durations 
for each day were adjusted to average values of training animals. Trials were tracked 
using EthoVision software (Noldus Information Technology). 
Rewarded alternation task in T-maze. Mice were maintained on a restricted feeding 
schedule at 85% of their free-feeding weight. Spatial working memory was assessed on a 
continuous black T-maze consisting of a start arm (60 x 10 cm), two identical goal arms 
(35 x 10 cm) and two return arms (90 x 10 cm), surrounded by a 14 cm high wall. Light 
sources in the room were adjusted in order to have the same light intensity in every arm 
of the maze (20 LUX) and the maze was surrounded by various prominent distal extra-
maze cues. The mice were habituated to the maze and to drinking condensed milk pellets 
over two days for 8 minutes every day. After habituation, animals were pre-trained daily 
over several days until the consumption of the reward reached minimum 80%. Each pre-
training daily session consisted of 4 trials and mice were run one trial at a time with an 
inter-trial interval (ITI) of approximately 10 minutes. During the pre-training, one milk 
pellet was available at the end of the two goal arms as reward and mice were allowed to 
consume the reward from both arms. For spatial nonmatching- to-place testing, mice 
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were assessed in a counterbalanced order and each trial consisted of a sample run and a 
choice run. On the sample run, the mice were forced either left or right by the presence of 
a door, according to a pseudorandom sequence (with equal numbers of left and right turns 
per session, and with not more than two consecutive turns in the same direction). A 
reward consisting of one milk pellet was available at the end of the arm. The time interval 
between the sample run and the choice run was approximately 15 seconds. The animal 
was rewarded for choosing the previously unvisited arm (that is, for alternating). 
Criterion point for a correct trial was that the whole animal (including the tip of the tail) 
entered the rewarded arm. Maze was cleaned between trials to avoid any potential odor 
cues. Each daily session consisted of 4 trials and mice were run one trial at a time with an 
ITI of approximately 10 minutes. 
Open field. The open field consisted of a white PVC enclosed arena (70 x 70 x 30 cm) 
under uniform lightning conditions (20 LUX). The arena was delimited into two regions 
using the EthoVision software: an outer zone and an inner zone, a central square area of 
35 x 35 cm equidistant from the walls. Mice were placed individually into one corner of 
the arena facing the sidewalls and were allowed to explore for 10 minutes. The time 
spent, velocity and total distance moved were recorded and video-tracked using 
EthoVision software. 
Novel object recognition task. The object recognition task took place in the open field 
apparatus. Mice were individually habituated to the arena for two days. During the 
training session, two identical objects A1 and A2 were placed into the open field at 20 cm 
from the walls and the mouse was allowed to explore for 10 minutes. On the short-term 
memory (STM) testing trial, after an ITI of 5 minutes spent in the home cage, the animals 
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were placed back into the open field, where one of the familiar objects was replaced by a 
novel object B, and allowed to explore freely for 10 minutes. The position of the novel 
object (left or right) was randomized between each mouse and each group tested. On the 
long-term memory (LTM) testing trial (24 hours after the STM testing trial), mice were 
allowed to explore the open field for 10 minutes in the presence of two objects: the 
familiar object A and a second novel object C. The novel object (B or C) was randomized 
in the STM or LTM sessions between each mouse and each group tested. All objects 
presented similar textures and sizes, but distinctive shapes and colors. Between trials, the 
objects were washed with 1% Anistel® solution to avoid the use of odor cues. The mice 
did not show any object preference before trials. Exploratory behavior was videotaped 
and video-tracked with the EthoVision software and it was measured post hoc using two 
stopwatches to record the time spent exploring the objects during the experimental 
sessions. A 20 seconds criterion of total exploration (or 10 minutes/session when the 
criterion was not reached) was used to score exploratory behavior. Object exploration 
was assessed only if the total time of exploration for each mouse was higher than 5 
seconds in the training session. Exploration was scored whenever the mouse sniffed or 
touched the object while looking at it (i.e., when the distance between the nose and the 
object was less than 2 cm). Climbing onto the object (unless the mouse sniffed the object 
it had climbed on) did not qualify as exploration. To measure recognition memory, a 
discrimination index (DI) was calculated as the difference in exploration time between 
the novel and familiar objects, divided by the total time spent exploring both objects 
[(novel arm – familiar arm) / (novel arm + familiar arm)]. 
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Spatial novelty preference in a Y-maze. Spatial novelty preference was assessed as 
described previously (Sanderson et al., 2009). Briefly, the spontaneous spatial novelty 
preference test was conducted using an 8 arm radial maze made from transparent Perspex 
with arms of 22 x 7 x 20 cm. The maze was placed into a room containing a variety of 
extra-maze cues. Mice were assigned two arms (“start arm” and “familiar arm”) while the 
entrance to the third arm (the “novel arm” during the subsequent test phase) was blocked 
off with a black door. Allocation of arms (familiar and novel) to specific spatial locations 
was counterbalanced within each experimental group. During the exposure phase mice 
were allowed to explore the two arms for 5 minutes in the one trial exposure test or for 2 
minutes five times, spaced by an ITI of 1 minute in the home cage, in the incremental 
training test. The mouse was then removed from the maze and returned to its home cage 
for a 1-minute interval between the exposure and test phases. During the test phase, mice 
were placed at the end of the start arm and allowed to explore all three arms for 2 
minutes. An entry into an arm was defined by a mouse placing the forepaws inside an 
arm. Similarly, a mouse was considered to have left an arm if the forepaws were placed 
outside the arm. Exploratory behavior was videotaped and video-tracked with the 
EthoVision software and the number of entries and the time that mice spent in each arm 
were recorded manually. For the test phase, a discrimination index DI = [novel arm – 
familiar arm] / [novel arm + familiar arm] was calculated for both arm entries and time 
spent in arms. 
Statistical analysis 
All statistical analyses were performed using GraphPad Prism 6 (GraphPad Softwares) or 
SPSS (IBM Corp) softwares. Unless otherwise stated, parametric data were analyzed by 
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t-test or one-way ANOVA followed by the Sidak, Holm’s or Tukey post hoc analysis for 
comparisons of multiple samples. Non-parametric data were analyzed by the Mann-
Whitney rank sum test or Kruskal-Wallis one-way analysis of variance on ranks followed 
by the Dunn post hoc analysis for comparisons of multiple samples. Probability 
distributions were compared using the Kolmogorov-Smirnov test. Statistical details of 
experiments can be found in the figure legends. P values <0.05 were considered 
statistically significant. Data are presented as mean ± SEM. 
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SUPPLEMENTAL FIGURES 
Figure S1. Expression and localization of Brevican in the cerebral cortex, related to 
Figure 1 
(A-D) Representative images showing the absence of Brevican sheath surrounding 
pyramidal cells or interneuron subtypes (empty arrowheads) other than PV+ basket cells 
(arrowheads). PCs: GFP-electroporated pyramidal cells, ChCs: chandelier cells in 
Nkx2.1CreERT2;RCE, VIP cells: VIP-Cre; RCE, SST cells: GIN mice.  
 (E) Percentage of PV+ interneurons enwrapped by Brevican protein at different postnatal 
developmental stages in the hippocampus (n = 3 mice). P30 data are the same as in 
Figure 1I. 
(F) Cumulative probability plot comparing Brevican fluorescence intensity levels at P15 
(n = 55 cells, 3 mice) and P30 (n = 142 cells, 4 mice) mice; Kolmogorov-Smirnov test. 
(G and H) Representative image (G) and percentage (H) of PV+ interneurons enwrapped 
by Brevican protein in the somatosensory cortex (n = 4 mice).  
(I) Density of VGlut1+PSD95+ synapses contacting the soma of PV+ cells at P15 (n = 7 
mice) and P30 (n = 6 mice); Mann-Whitney test. P15 and P30 data are the same as the 
controls in Figure S3E and Figure 3D, respectively. 
(J-O) Representative images and percentage of Syt2+ (J-L, n = 4 mice) and GAD65+ (M-
O, n = 3 mice) inhibitory terminals contacting the soma of PV+BCAN+ cells.  
(P and Q) Histograms of normalized intensity ratios and dye separation for a three-color 
STORM experiment using Bassoon-AF647, Homer-CF660 and Brevican-CF680 (P) and 
for a two-color STORM experiment using Brevican-AF647 and Bassoon-CF680 (Q). 
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(R and S) Radial (lateral) distribution of Brevican and Bassoon (R) or Homer1 (S). 
Analysis of 51 (R) and 41 (S) face-view synapses from 6 experiments. Scale bars equal 
20 µm (A-D), 100 µm (G), 5 µm (J, M), 1 µm (K, N). 
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Figure S2. Characterization of Brevican+ and Brevican- cells, related to Figure 2 
(A) Correlation between the PV and Brevican protein intensities in PV+ cells (Spearman 
correlation, n = 44 cells, 3 mice). 
(B) Density of VGlut1+ boutons (n = 7 mice) and PSD95+ clusters (n = 9 mice) 
contacting the soma of BCAN+ and BCAN- PV cells. Student t-test. 
(C) Correlation between the number of Brevican “coats” (see supplemental experimental 
procedures for details) and the number of VGlut1+ inputs contacting PV+ interneurons 
(Pearson correlation, n = 41 cells, 3 mice). 
 (D) I/O curves showing the spike frequency of BCAN+ (n = 22 cells, 9 mice) and 
BCAN- (n = 13 cells, 9 mice) PV+ cells in response to current injections (left Y-axis, 
solid lines). Note that the input-output curve was similar between the two populations of 
basket PV+ cells. Two-way ANOVA, F (1, 346) = 0.0170. 
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Figure S3. Effect of Brevican deletion on the wiring of PV+ interneurons, related to 
Figure 3 
(A) Density of VGlut1+ boutons (n = 6 WT, 4 Bcan-/-) and PSD95+ clusters (n = 7 WT, 7 
Bcan-/-) contacting the soma of PV+ cells at P30.  
(B) Density of VGlut1+ boutons, PSD95+ clusters and VGlut1+PSD95+ synapses 
contacting the soma of PV+ cells in P15 wild type (WT, n = 7 mice) and Bcan-/- (n = 7 
mice) mice.  
(C) Cumulative probability plots comparing PV fluorescence intensity levels in P15 wild 
type (WT, n = 75 cells, 8 mice) and Bcan-/- (n = 44 cells, 3 mice) mice; ns: no significant 
difference.  
 (D-F) Representative images and thresholded binary images (D and E) illustrating 
VGlut1+PSD95+ synapses contacting the soma of PV+ cells, and synaptic density (F), in 
WT (n = 6 mice) and Bcan-/- (n = 8 mice) mice at P60. 
(G) Schematic drawing highlighting the synapses analyzed in the following experiments. 
(H-J) Representative images, thresholded binary images (H and I) and synaptic density 
(J). Images illustrate Syt2+ boutons (n= 5 WT, 4 Bcan-/-), Gephyrin+ clusters (n = 12 WT, 
11 Bcan-/-) and Syt2+Gephyrin+ synapses (n = 5 WT, 4 Bcan-/-) contacting the soma of 
PV+ cells. 
(K) Cumulative probability plots comparing the size of Syt2 puncta in wild type (WT, n = 
61 cells, 6 mice) and Bcan-/- (n = 82 cells, 4 mice) mice. 
(L-N) Representative images and thresholded binary images (L and M) illustrating 
CB1+GAD65+ boutons contacting the soma of PV+ interneurons, and synaptic density 
(N) in WT (n = 5 mice) and Bcan-/- (n = 6 mice) mice . 
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(O-S) Representative traces, frequency, amplitude, rise and decay time of mIPSCs in WT 
(n = 11 cells, 4 mice) and Bcan-/- PV+ cells (n = 16 cells, 3 mice). 
(T-X) Representative traces, frequency, amplitude, rise and decay time of sEPSCs in WT 
(n = 11 cells, 1 mouse) and Bcan-/- PV+ cells (n = 10 cells, 2 mice). 
Student t-test (A, F, N, R, S, V, W, PSD95+ clusters in C, and Gephyrin+ clusters in J), 
Mann-Whitney test for (J, P, Q, U, X and VGlut1+ boutons in C). Kolmogorov-Smirnov 
test (B and K). Scale bars equal 1 µm (D, E, H, I), 2 µm (L, M).  
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Figure S4. Strategy to knockdown Brevican in PV+ interneurons, related to Figure 4 
(A and B) Diagram of the AAV cre-dependent constructs expressing mCherry and 
shBcan (A), or Brevican isoforms tagged with HA (B). 
(C) Representative immunoblots from HEK293T cells co-transfected with Cre-GFP and 
Brevican1-HA or Brevican2-HA (n = 2 independent wells). 
(D-F) Representative immunocytochemistry images (D) and immunoblots (E and F) 
illustrating downregulated Brevican expression upon co-transfection with plasmids 
expressing shRNA for Brevican (shBCAN). Cells were co-transfected with Cre-GFP, 
shBrevican, and Bcan1-HA or Bcan2-HA; n = 6 independent wells except Bcan1+shGFP 
and Bcan1+shBCAN where n = 9. Kruskal-Wallis test for Bcan1 and one-way ANOVA 
for Bcan2. Scale bar 20 µm. 
(G) Density of VGlut1+ boutons (n = 67 WT cells and 45 Brevican KD cells, from 5 
mice) and PSD95+ clusters (n = 22 WT cells and 23 Brevican KD cells, from 3 mice) 
contacting the soma of PV+ cells. Student t-test. 
(H) Density of Gephyrin+ clusters and Syt2+Gephyrin+ synapses (n = 28 WT cells and 
25 Brevican KD cells, from 3 mice) contacting the soma of PV+ cells. Mann-Whitney 
test. 
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Figure S5. Overexpression of Brevican in PV+ interneurons and astrocytes, related 
to Figure 5 
(A) Representative images of PV+ interneurons infected in vivo with AAVs expressing 
Brevican1-HA or Brevican2-HA and immunostained with BCAN antibody. 
(B) Density of VGlut1+ boutons (n = 25 Bcan-/-cells and 23 BCAN1 rescued cells, from 5 
mice) and PSD95+ clusters (n = 40 WT cells and 40 BCAN1 rescued cells, from 5 mice) 
contacting the soma of PV+ cells. 
(C) Density of VGlut1+ boutons (n = 24 Bcan-/-cells and 23 BCAN2 rescued cells, from 6 
mice) and PSD95+ clusters (n = 50 WT cells and 34 BCAN2 rescued cells, from 5 mice) 
contacting the soma of PV+ cells. 
(D) Functional protein domains in BCAN1 and BCAN2 sequences and design of a 
BCAN2 mutant that lacks the GPI-anchor (BCAN2-GPI). 
(E) Representative image showing how BCAN2-GPI is retained in the cytoplasm of PV+ 
cells. 
(F) Density of VGlut1+ boutons, PSD95+ clusters and VGlut1+PSD95+ synapses (n = 30 
Bcan-/-, 21 BCAN2-GPI expressing cells, 4 mice) contacting the soma of PV+ cells. 
(G) Density of Gephyrin+ clusters in Bcan-/- (n = 19 cells, 5 animals), BCAN1 (n= 13 
cells, 4 animals) and BCAN2 (n = 17 cells, 3 animals) PV+ cells. 
(H) Comparison between the density of VGlut1+ boutons in Brevican KD cells (45 cells, 
from Figure S4G) and Bcan-/- cells (49 cells, pool of data from Figure 5B and S5C). 
(I) Percentage of PV+ cells that are surrounded by BCAN1-HA secreted from astrocytes 
infected with GFAP-CreGFP and BCAN1-HA expressing viruses. 
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(J) Representative image showing CA2 pyramidal neurons surrounded by BCAN1 
secreted from astrocytes that had been infected with GFAP-CreGFP and BCAN1-HA 
Cre-dependent virus. 
(K) Density of VGlut1+ boutons and PSD95+ clusters contacting the soma of PV+ cells 
in Bcan-/- mice infected with the control virus only (GFAP-CreGFP, n = 8 for VGlut1+ 
boutons and 6 mice for PSD95+ clusters) or together with BCAN1 (n = 4 mice) or 
BCAN2 (n = 3 mice for VGlut1+ boutons and 6 mice for PSD95+ clusters) expressing 
virus. 
(L) Cumulative probability plots comparing PV fluorescence intensity levels in Bcan-/- 
mice in which astrocytes had been infected with the control virus only (GFAP-CreGFP, n 
= 360 cells, 6 mice) or together with BCAN1 (n = 202 cells, 4 mice) or BCAN2 (n = 227 
cells, 3 mice) expressing virus. Note that neither BCAN1 nor BCAN2 were able to rescue 
the PV level, however the PV level in mice that overexpressed Bcan2 in astrocytes was 
even lower than in Bcan-/- mice, Kolmogorov-Smirnov test (p<0.0001) whereas no 
significant differences were observed between Bcan1 and Bcan-/- mice, Kolmogorov-
Smirnov test (p>0.05). 
(M-R) Representative images (M-O) and firing traces (P-R) for Bcan-/- (same as in Figure 
3O), BCAN1 and BCAN2 overexpressing PV+ cells. (S) are insets from (P-R) illustrating 
the similar spike shape of Bcan-/-, BCAN1 and BCAN2 rescued cells. 
(T-W) Intrinsic electrophysiological properties comparing Bcan-/- (n = 53 cells, 13 mice), 
BCAN1 (n = 13 cells, 4 mice) and BCAN2 (n = 32 cells, 5 mice) overexpressing PV+ 
cells. Note that Bcan-/- cells used for comparison were a pool of the cells shown in Figure 
3 and YFP+HA- cells from the injected mice. Mann-Whitney test (B, C, H, 
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VGlut1+PSD95+ synapses in F), one-way ANOVA (G, K, U, V, W), Student t-test (F, 
VGlut+ boutons and PSD95+ clusters), Kolmogorov-Smirnov test (L), Kruskal–Wallis 
test (T). Scale bars equal 10 µm (A, E, J, M, N, O). 
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Figure S6. Interactions of Brevican with AMPA and potassium channels, related to 
Figure 6 
(A) Representative immunoblot illustrating that pull-down of GluA1 from wild type 
hippocampal lysates previously digested with ChABC co-immunoprecipitates Brevican, 
showing that BCAN-GluA1 interactions is independent of the chondroitin sulfate chains. 
Note that pull-down of NMDA2B, mGluA2-3 or control IgG fails to co-
immunoprecipitate Brevican (n = 2 Co-IP independent experiments). 
(B and C) Quantification (B) and representative immunoblots (C) of GluA4 protein in the 
indicated cell fractions (n = 7-11 mice per genotype). 
(D and E) Immunoblots of the fractionation controls showing enrichment of GAPDH in 
cytoplasmic fractions, of Na,K-ATPase and Cadherin13 in membrane fractions, and of 
PSD95 in synaptosomes. 
(F) Density of GluA1+VGlut1+ clusters in the stratum radiatum of the hippocampus, a 
region largely populated by pyramidal cell dendrites, in WT (n = 3 mice) and Bcan-/- (n = 
3 mice) mice. The similar density of GluA1+VGlut1+ clusters suggests a PV-specific 
deficit in GluA1 synaptic delivery. 
(G) Density of VGlut1+ boutons and PSD95+ clusters contacting the soma of PV+ cells 
in PV-Cre; GluA1 conditional mutants (n = 10 mice) compared to controls (n = 6 mice). 
(H) Representative immunoblots illustrating that pull-down of Kv1.1 and Kv3.1b from 
WT hippocampal lysates co-immunoprecipitate Brevican (n = 2 mice). Note that although 
a non-specific band is detected, the difference in its intensity indicates that Kv1.1 and 
Kv3.1b fail to co-immunoprecipitate Brevican in Bcan-/- hippocampal lysates. 
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(I) Representative immunoblots illustrating that pull-down of GluA1, Kv1.1 and Kv3.1b 
from Bcan-/- hippocampal lysates co-immunoprecipitate BCAN1 and BCAN2 from 
transfected HEK cells (n = 1 Co-IP experiment from 2 independent transfections. 
Student t-test (B) and Mann-Whitney test (F and G).  
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Figure S7. Experience can modify PV and Brevican expression, related to Figure 7 
(A and B) Representative immunoblots (A) and analysis (B) of Lhx6 protein levels in 
hippocampal lysates from epilepsy patients (n = 4) compared to controls (n = 4). 
(C) Morris Water maze (MWM) learning curve (symbols indicate spatial cues). 
(D) Reference spatial memory on day 10 during the probe test in the Morris Water Maze 
(MWM) (n = 5 mice). 
(E) Cumulative probability plots comparing PV fluorescence intensity levels in control (n 
= 44 cells, 3 mice) and MWM trained mice (n = 79 cells, 4 mice) at day 4. 
(F and G) Cumulative probability plots comparing the PV (F) and Brevican (G) 
fluorescence intensity levels in control (n = 60 cells, 4 brains) and MWM trained (n = 60 
cells, 4 mice) mice after 10 days. 
(H and I) Representative images illustrating Brevican levels in the hippocampus of mice 
that were trained for 10 days in the MWM compared to swimming controls. Full 
arrowheads show colocalization, open arrowheads show no colocalization. Scale bar, 20 
µm. 
(J) Cumulative probability plots comparing PV fluorescence intensity levels in control (n 
= 30 cells, 3 mice) and mice housed in an enriched environment (EE) for 30 days (n = 34 
cells, 3 mice). 
(K and L) Cumulative probability plots comparing Brevican (K, n = 65 control, 63 EE 
cells) and PV (L, 183 control, 149 EE cells) fluorescence intensity levels in control (5 
mice) and mice housed in an enriched environment (EE) for 4 days (5 mice). 
(M) Density of VGlut1+ boutons contacting the soma of PV+ cells in control (n = 3 mice) 
and mice housed in an enriched environment (EE) for 4 days (3 mice). 
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(N and O) Bcan1 (N) and Bcan2 (O) mRNA expression relative to that of Syt-2 in control 
(n = 5 mice) and in mice housed in an enriched environment (EE) for 4 (n = 5 mice) and 
30 (n = 5 mice) days. 
(P) Ratio between the mRNA expression of Bcan1 and Bcan2 in control (n = 5 mice) and 
mice housed in an enriched environment (EE) for 4 (n = 5 mice) and 30 (n = 5 mice) 
days.  
Mann-Whitney test (B, M), Kolmogorov-Smirnov test (E, F, G, J, K, L), and one-way 
ANOVA (D, N, O, P).  
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Figure S8. Brevican deletion does not affect spontaneous locomotor activity, related 
to Figure 8 
(A-D) Behavior of wild type (WT, n = 19) and Bcan-/- (n = 20) mice showing 
representative movement paths of individual mice (A), as well as time spent in the center 
(B), total distance traveled (C) and velocity (D) across the entire session in the open-field. 
ns: no significant difference. Note that anxiety and spontaneous locomotor activity are 
intact in Bcan mutant mice. 
(E-H) Analysis of the one trial and incremental exposure novelty preference test showing 
the number of entries (E), time spent (F), distance traveled and velocity (H) in the “start” 
arm (n = 5 mice per genotype). Number of entries made in the “familiar” and “novel” 
arms (I), the total time spent in the “familiar” and “novel” arms (J), and the 
discrimination index for the number of entries (K) and the time spent in the arms (L), for 
WT (n = 11) and Bcan-/- (n = 10) mice. 
(M and N) Distance traveled and velocity for WT and Bcan-/- mice during the novel 
object recognition test after 5 minutes ITI (n = 19 WT and n = 20 Bcan-/-) and 24 hours 
ITI (n = 18 WT and n = 16 Bcan-/-). 
(O) Schematic illustration of the experiment shown in Figure 8N-Q. PV-Cre mice 
received multiple bilateral injections with one of the indicated AAVs in the dorsal 
hippocampus at P12 and were tested for the novelty preference. 
(P-S) Number of entries, time spent in the “start” arm, distance traveled and velocity for 
WT (n = 11) and Bcan KD mice (n = 13) in the novelty preference test. 
One-way ANOVA (E, F, G, H, I, J, M, N), Student t-test (A, K, L, R, S), and Mann-
Whitney test (B, C, D, P, Q). 
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SUPPLEMENTAL TABLES 
 
Table S1. Summary comparing the intrinsic properties of BCAN+ and BCAN- PV+ 
interneurons, Related to Figure 2. 
Values are provided for each measurement as mean ± SEM. The column to the right 
indicates the p value (Student’s t-test or Mann-Whitney test) of statistical comparisons 
for each row’s variable between BCAN+ and BCAN- cells. Abbreviations: Vrest – 
Resting Membrane Potential, AP – Action Potential, fAhP – fast-Afterhyperpolarisation, 
MaxFF – Saturating Firing Frequency, V-sag – voltage relaxation. N indicates number of 
cells in each condition (for V-sag only, N = 19 Brevican+ and 12 Brevican- cells). 
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Table S2. Summary comparing the intrinsic properties of wild-type and Bcan-/- PV 
interneurons, Related to Figure 3. 
Values are provided for each measurement as mean ± SEM. The column to the right 
indicates the p value (Student’s t-test or Mann-Whitney test) of statistical comparisons 
for each row’s variable between wild-type (WT) and Bcan-/- PV interneurons. 
Abbreviations: Vrest – Resting Membrane Potential, AP – Action Potential, fAhP – fast-
Afterhyperpolarisation, MaxFF – Saturating Firing Frequency, V-sag – voltage 
relaxation. N indicates number of cells in each condition (for V-sag only, N = 48 WT and 
40 Brevican-/- cells). The WT group includes all cells in BCAN+ and BCAN- groups 
(Table S1), plus 14 cells for which Brevican immunostaining was inconclusive.  
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Table S3. Summary comparing the intrinsic properties of wild-type and Bcan KD 
(shBrevican) PV interneurons, Related to Figure 4. 
Values are provided for each measurement as mean ± SEM. The column to the right 
indicates the p value (Student’s t-test or Mann-Whitney test) of statistical comparisons 
for each row’s variable between wild-type (WT) and Bcan KD PV interneurons. 
Abbreviations: Vrest – Resting Membrane Potential, AP – Action Potential, fAhP – fast-
Afterhyperpolarisation, MaxFF – Saturating Firing Frequency, V-sag – voltage 
relaxation. N indicates number of cells in each condition (for V-sag only, N = 48 WT and 
22 shBrevican cells). N indicates number of cells in each condition. The WT group is the 
same as in Table S2. 
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Table S4.  
Summary comparing the intrinsic properties of Bcan-/-, BCAN1 and BCAN2 
overexpressing PV interneurons, Related to Figure 5. 
Values are provided for each measurement as mean ± SEM. The columns to the right 
indicate the p value (one-way ANOVA or Kruskal–Wallis test) of statistical comparisons 
for each row’s variable between Bcan-/-, BCAN1, and BCAN2 overexpressing PV 
interneurons followed by Holm-Sidak’s multiple comparison test when significant 
differences were found. Abbreviations: Vrest – Resting Membrane Potential, AP – 
Action Potential, fAhP – fast-Afterhyperpolarisation, MaxFF – Saturating Firing 
Frequency, V-sag – voltage relaxation. N indicates number of cells in each condition. The 
Bcan-/- group includes all cells in Bcan-/- group from Table S2, plus 12 YFP+HA- cells 
from the injected mice. 
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Oligonucleotides  Sequence 
shBCAN  Fw CTAGGCAAGCAGAACCGCTTCAATG 
CCTGACCCACATTGAAGCGGTTCTGTTGCTTTTTG 
 Rv AATTCAAAAAG 
CAAGCAGAACCGCTTCAATGTGGGTCAGGCATTGAAGCGGTTCTGCTTGC 
Bcan1 ISH 
probe 
Fw TGCACCCCTGAGGAGCAAGAC 
 Rv CGGGTAAAACCTGAGGCCC TTGTG 
Bcan2 ISH 
probe 
Fw GTAATTCTGCTGAAGGCTCAA 
 Rv TGGGTACAAAGCAGTTTAATACAG 
HA tag 
sequence  
Fw TCTAGAGCCACCATGATACCACTGCTTCTGTCCCTGCTGGCCGCTCTGGT 
 Rv TTGGGTCAGGACCAGAGCGGCCAGCAGGGACAGAAGCAGTGGTA 
TCATGGTGGCCTAGAA 
Bcan signal 
peptide 
Fw CCTGACCCAAGCCCCTGCCGCCCTCGCTGA 
TTACCCATACGATGTTCCAGATTACGCTAGATCTA 
 Rv AGATCTAGCGT 
AATCTGGAACATCGTATGGGTAATCAGCGAGGGCGGCAGGGGC 
Bcan1 qPCR Fw CTATGTTTGCCAGGCTATGGGGG 
 Rv TGCCTCCTCCCAACTCCTTCGTG 
Bcan2 qPCR Fw GTCCTGGCAGGCACCTCAGTG 
 Rv GCATTGAGCCTTCAGCAGAA TTAC 
Syt2  Fw ACGTGCCCACAGCTGGGAAGCTC 
 Rv GTCTCTTACCGTTCT GCATCAGG 
Gfap  Fw GGGACAACTTTGCACAGGACCTC 
 Rv GGTGGCTTC ATCTGCCTCCTGTC 
 
Table S5. Oligonucleotide sequences. Related to Key Resources Table and STAR 
Methods. 
 
 
 
